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Abstract  
Aim: The purpose of the study was to estimate the prevalence of selected modifiable risk 
factors of non-communicable diseases (NCDs), smoking, alcohol consumption, physical 
inactivity, fruits and vegetables consumption, overweight and obesity, hypertension, diabetes 
and abnormal lipid profiles, and to investigate the association between hypercholesterolemia 
with selected socio-demographic factors and selected NCD risk factors among 25-74 year old 
citizens of urban area of Yangon Region, Myanmar. 
 
Materials and Methods: 
A household based cross sectional study conducted in urban area of Yangon region, Myanmar 
with multi-stage cluster sampling of 758 participants who were 25-74 years old. The 
methodology was adapted to the WHO STEPwise approach to chronic disease risk factor 
surveillance. In STEP (1), socio-demographic characteristics and NCD risk factors were 
undertaken by questionnaire. In STEP (2) physical anthropometric measurements and blood 
pressure were measured, and in STEP (3), fasting lipid profiles and blood glucose were 
investigated. 
 
Result: 
The main findings of the present study was high prevalence of NCDs risk factors, low intake 
of fruits and vegetables consumption (82.3%), overweight (44%), hypertension (48.2%), 
diabetes (18%), and based on Framingham risk scores, 33.2% of males and 22.2% of females 
had a moderate to high risk of developing CHD the next 10 years. Furthermore, an alarming 
high prevalence of hypercholesterolemia of 56.6% was reported. In multivariable analysis, 
high age, low education, low income and tobacco use were associated with 
hypercholesterolemia. 32 % of the total respondents lived with three or more risk factors of 
NCDs among the study population. 
 
Conclusion: 
The present study shows that the prevalences of NCD risk factors in the urban population of 
the Yangon region are generally high. Compared with a previous study from the same area 
conducted in 2003, the prevalences of the risk factors seem to be on rise. These were gender 
differences with high prevalence in males than females for smoking, current alcohol drinking, 
and hypercholesterolemia, and lower prevalence for males regarding overweight and obesity. 
viii 
 
Almost all adult urban citizens of Yangon have more than one the risk factors present, and 
one third has 3-5 risk factors present. Based on the Framingham risk estimates, more that one-
fourth of the population have moderate to high risk of developing CHD within the next 10 
years.  
The present study indicates social inequity in the occurrence of hypercholesterolemia which is 
higher among those with low income and education. An increasing trend in NCD risk factors 
will lead to increase in NCDs. This will put an enormous pressure on the Myanmar health 
system, and prevention strategies should be given high priority.  
 
Keywords: risk factors, non-communicable diseases, prevalence, Yangon, Myanmar 
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(I) BACKGROUND  
1. Background of the Republic of the Union of Myanmar 
1.1 Geography  
The Republic of the Union of Myanmar, previously known as Burma, is the largest country in 
the South-East Asia region. It is bordered on the north and north-east by China, on the east 
and south-east by Laos and Thailand, on the south by the Andaman Sea and the Bay of 
Bengal and on the west by Bangladesh and India 1. The country's extensive coastline, 
stretching from southern to northwestern parts of the country, provides access to sea routes 
and marine resources 1. Flat land areas, which are enclosed within the mountain barriers, are 
mostly agricultural land with high population density. Myanmar is often called "The Golden 
land", because of its golden paddy fields and pagodas. 
 
1.2 Demography 
The total population of Myanmar is estimated to be 60 million people. About 70% of the 
population lives in rural areas1. However, the urban population has been growing rapidly by 
2.5 % annually 2. The annual growth rate was estimated to be 1.01%(2012) 1. 
 
Approximately one-third was under 14 years old; 25-59 year age-groups accounted for 62%, 
and 8.8 % was 60 years and above 1. The sex ratio was estimated to be 98.8 males per 100 
females in 2011 1. The population density varies between states and regions, Yangon region 
was the highest densely populated area (666 persons per square kilometers of land) and the 
mountainous Chin state was the most sparsely populated area (88 persons per square 
kilometers of land) 3. The national poverty index reported a decline in poverty from 32% in 
2005 to 26% in 2010, with a greater decrease in urban than in rural areas 4. 
 
The official language in Myanmar is Burmese 1. Myanmar, however, has 135 national ethnic 
groups and more than 100 languages and dialects 1. Myanmar is known as a Buddhist country 
with 89 % of people being Buddhists 1. The others are Christians (4.9%), Muslims (3.9%), 
Hindus (0.5%) and Animists (1.2)% 1.  
 
1.3 General Health Status of Myanmar 
Under the guidance of the National Health Committee (NHC), the Ministry of Health takes 
the responsibility of providing preventive, curative and rehabilitative services in order to raise 
the health status of the entire population. At township level, health services are provided by 
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the township hospital, station hospitals, urban and rural health centers and sub-rural health 
centers.  The health professionals at community levels provide health services using a primary 
health care (PHC) approach with the participation of voluntary health workers such as 
auxiliary midwives and community health workers 5.  
 
However, understaffing at various levels have been a major problem in public health care 
system regarding issues of access and coverage 5. The distribution of government medical 
doctors across states and divisions varied from 6 to 59 per 100,000 populations and that of 
nurses vary from 10 to 160 per 100,000 populations 5. Yangon and Mandalay regions, had the 
highest concentration of medical doctors in 2009 5. 
 
The Myanmar Health care system has a pluralistic mix of public and private system both in 
the financing and service provision 5. Both public and private service providers are involved 
in the health care system throughout the country. Government health expenditures have 
increased annually on both current and capital from 1.0% in 2010-2011 to 3.1% in 2012-2013 
of the total government expenditures 1. The world health organization (WHO) estimated that 
the health expenditure per capita increased in Myanmar from 2.8 USD in 2002 to 19.8 USD in 
2012 6. Myanmar national death rate at 900 deaths per 100,000 populations stood among the 
highest in the South-East Asian countries, while the gross national income was at the lowest 7. 
In general, there are three main financial sources namely public, private and external sources 
contributing in Myanmar health expenditures 8. 
 
The average life expectancy of Myanmar people has increased gradually from 54.4 years in 
1990 to 60.7 years in 2010 9. Since the people tend to live longer, their probability of getting 
non-communicable and chronic diseases also increases with age.   
 
1.4 Non-communicable diseases 
Non-communicable diseases (NCDs) are globally the leading causes of morbidity and 
mortality. WHO defines NCDs as “diseases of long duration, and with generally slow in 
progression” 10. However, the threat of NCDs to today’s world is not slow in progression.  
 
In 2010, NCDs were responsible for 65% of the global deaths (34.5 million deaths) 11 and 
54% of disability-adjusted life years (DALYs) worldwide 12. The figures are expected to 
increase to 73% and 60%  respectively by the year 2020 10. More than 80% of NCD deaths 
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occurred within low and middle income countries, and nearly one out of four deaths occurred 
before the age of 60 years in 2008 13.  
 
NCDs contributed globally four out of the top five leading causes of death in 2010: ischemic 
heart disease (first), stroke (second), chronic obstructive pulmonary diseases (COPD)(third), 
and lung cancer (fifth); in the South-East-Asia region: ischemic heart disease (first), stroke 
(second), Diabetes (fifth) 11. The South-East Asia region is facing an epidemic of NCDs 
causing 7.9 million deaths or 55% of total deaths13. One-third occurred before age 60 13. It is 
reported that NCDs in South-East Asia region is on rise, however in Myanmar, data on NCDs 
is scarce.  
 
The burden of diseases estimates for Myanmar indicates increasing trends of NCDs from 
1990-2010: stroke (35% increase), ischemic heart disease (41% increase), diabetes mellitus 
(39% increase), hypertensive heart disease (21% increase), and lung cancer (54% increase) 14. 
In Myanmar, NCDs were reportedly to be the most common causes of deaths in 2008, 
contributing 40% of all deaths 13. About 30% of NCD related deaths occurred before the age 
of 60 15.  
 
Globally, there is a shift in disease pattern from infectious diseases to chronic diseases due to 
a more westernized lifestyle and urbanization. The risk factors of NCDs include low 
education, stress, tobacco use, unhealthy diet, physical inactivity, overweight and obesity, and 
biological risk factors such as high blood glucose, high blood pressure and abnormal blood 
lipid profile 10. These factors are interlinked with each other and linked with urbanization, 
poverty and globalization 10. An increasing trend in NCDs risk factors has been observed 
globally during the two decades from 1990 to 2010;  blood pressure (27% increase), smoking 
(3% increase), alcohol use (28% increase), low fruit (29% increase), high body-mass index 
(82% increase), and high fasting plasma glucose(58% increase) 16. An increase in such risk 
factors may lead to raised NCDs’ burden.  
 
In 2012, the World Health Assembly endorsed the United Nations(UN) political declaration 
on non-communicable diseases to reduce 25% of avoidable NCD-related mortality by 2025 
(the 25 by 25 goal) 17. It provided a greater political attention to NCDs globally. Many high 
income countries have managed to reduce the mortality of NCDs with major investments in 
prevention and treatment programs of NCDs 18,19. However, low-income countries still face 
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huge challenges to control the rise in NCDs with their limited resources. Myanmar, like other 
least-developed countries, encounters double burden of diseases. It therefore was suggested to 
perform a stepwise approach to NCD planning and action as an appropriate method 
particularly for middle-income and low-income countries, to meet UN commitments on 
NCDs 20. For this strategy, the estimation of the burden of NCDs and their risk factors were 
crucial for planning an effective national health policy for NCDs 20.  
 
It has been reported that mitigating common modifiable risk factors can reduce 80% of 
cardiovascular diseases and diabetes, and 40 % of cancers 21. Rapid and substantial reduction 
in mortality can be achieved from the improvement of risk factors of NCDs in a population 22. 
Unhealthy diet, tobacco use, high blood pressure and high blood glucose were found to be 
among the top five risk factors contributing to most of the disease burden in Myanmar 14.  
 
Currently, there are two studies on NCD-risk factors from Myanmar. A WHO STEPs survey 
in Yangon region conducted in 2003-2004 and a nationwide WHO STEPs survey undertaken 
in 2009. These studies provided information on risk behaviors such as tobacco use, alcohol 
consumption, and physical risk factors such as obesity and hypertension. Biochemical 
measurements i.e. fasting blood glucose and lipids were also investigated in 2003-200423, but 
not in 2009 24. 
 
1.5 Risk factors of non-communicable diseases 
1.5.1  Tobacco Use 
Tobacco use is a risk factor for a number of chronic diseases including various cancers, in 
particular lung cancer, and heart disease, stroke, COPD and diabetes 25,26. In spite of being 
avoidable, tobacco is related to 6 million deaths every year 27. Tobacco consumption 
including second-hand smoking takes up second top position in both global and South-East 
Asia region when risk factors are ranked by attributable burden of diseases 16. Moreover, the 
South-East Asia Region has the highest tobacco consumption, consuming 8% of world 
cigarette production (488 billion cigarettes) in 2007 28.  
 
Smokeless tobacco use, such as tobacco chewing may lead to cancers, cardiovascular disease 
(CVD) and other circulatory diseases 29,30. Tobacco chewers have more than 10 times higher 
risk of oral cancer than non-users 31. Betel quid chewing and smoking is reported to be 
associated with oral cancer and pre-cancer in Myanmar 32. In Myanmar, the prevalence of 
5
smokeless tobacco use was 30% (51% among males and  16% among females ) while the 
overall prevalence of smoking was 22 % (45 % among males and 8 % among females) in 
200924. Second hand smoking was prevalent at 55 % in homes and 39 % at workplaces 24. The 
Global Health Professions Student survey (GHPSS) of Myanmar in 2007 indicated that 22 % 
of dental students, 12 % of medical students, 4 % of pharmacy students currently smoked 
cigarettes and 13 % of dental students, 11 % of medical students and 4 % of pharmacy student 
used other form of tobacco products 33. 
 
1.5.2 Alcohol Consumption  
Harmful use of alcohol causes about 2.5 million deaths globally each year 34. Alcohol 
drinking is a leading risk factor of disease burden of both developed and developing 
countries34. Apart from the direct effects of intoxication and addiction, harmful use of alcohol 
consumption causes esophageal cancer, liver diseases, CVDs, road traffic accidents and 
homicide 34. Although light and moderate consumption of alcohol beverage have protective 
effect on cardiovascular diseases and diabetes35-37, the overall impact of the burden of disease 
is harmful 25.  
 
An estimated 350,000 people died in South-East Asia region in 2004 13, and alcohol 
consumption was ranked by attributable burden of disease 2012 as the highest 6th in South-
East-Asian region and highest 3rd position globally 16. A recent study reported a higher 
prevalence of alcohol consumption among males than among females in the South-East Asia 
Region 10. A similar trend is seen in Myanmar. Local spirit, whisky, beer, seasonal palm juice, 
and wine are common beverages in Myanmar. The 2009 survey reported that the prevalence 
of current drinkers in the last 30 days was 13% and there were substantial differences in 
alcohol consumption between males (31%) and females (1.5%). However, 35 % of males and 
95% of females were found to be life-abstainers 24.  
 
1.5.3 Fruits and Vegetables consumption 
Urbanization and globalization has changed the dietary pattern of Myanmar residents from 
traditional diets such as fruits and vegetables with high fiber and low fat to unhealthy diets 
containing high levels of saturated fats, trans-fats, high amount of sugars and salt. Foods that 
are high in fats and sugars promote obesity, a major risk factor for CVDs, diabetes and 
cancers 38. Adequate consumption of fruits and vegetables may reduce the burden of NCDs 
such as CVDs, colorectal cancer and gastric cancer 38,39. 
6
 It has been estimated that 2.7 million lives could be saved globally each year if fruits and 
vegetables consumption were increased 40. Globally, 26.7 million DALYs are attributable to 
inadequate consumption of fruits and vegetables 41. In South-East-Asia region, half a million 
deaths were related to low consumption of fruits and vegetables 25. 
 
Myanmar is an agricultural country, and fresh fruits and vegetables are available throughout 
the season at low costs. A study in 2009 reported that the mean number of servings of fruits 
and vegetables on average per day was 2.6, and about 90% of Myanmar population consumed 
less than the WHO recommended five servings of fruits and vegetables on average per day 24. 
 
1.5.4 Physical Inactivity 
Physical inactivity is estimated to cause approximately 3.2 million deaths globally each 
year10. Individuals with inadequate physical activity had 20-30 % higher risk of various kinds 
of NCDs than those performing moderate physical activity 42. Approximately 21-25% of 
breast and colon cancer burden, 27% of diabetes and about 30% of ischemic heart disease 
burden are attributable to low physical activity 25. Recent study showed that elimination of 
physical inactivity could prevent 6-10% of major NCDs and increased life expectancy 43.   
 
Physical inactivity is estimated to cause 5.1% of deaths in South-East-Asia region25. In 
Myanmar, 10% of males and 14% of females did not meet the minimum recommendation for 
physical activity(<600 Metabolic Equivalent of task (MET)-minutes ) 24,44. Mean duration of 
time spent on physical activity was 182 minutes per day in 2009 24.  
 
1.5.5 High Blood Pressure 
High blood pressure, a major risk factor for NCDs, is estimated to cause 13 % of global 
deaths25. About half of total deaths from stroke and ischemic health diseases are attributable 
to hypertension worldwide 25. High blood pressure was the leading attributable burden of 
diseases, both globally and in South-East Asia Region, and has increased with 27% from 1990 
to 2010 16.  
 
The prevalence of hypertension is higher in low income countries than in  middle and high 
income countries 10, and is widespread in the South-East Asia region 13. Hypertension 
contributed to 1.5 million deaths worldwide and more than one third of the South-East Asian 
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population were hypertensive 10. Moreover, the risk of dying from hypertension is more than 
double in low and middle countries compared to high income countries 25. The prevalence of 
hypertension in Myanmar was  reported to be 34 % in 2003/04 in Yangon region 23 and 30% 
in a nationwide study from 2009 24. Low level of hypertension control has been reported 24,45.  
 
1.5.6 Overweight and Obesity 
Globally overweight and obesity is estimated to cause 2.8 million deaths every year 10. 
Adverse metabolic effect of overweight and obesity impact on the blood pressure, serum 
cholesterol, triglyceride and insulin resistance leading to increased risk of  CVD, ischemic 
heart disease and diabetes mellitus 25. Increased body mass index (BMI) is also associated 
with various types of cancers such as breast, colon, kidney 25.  
 
Annually, 35,000 deaths were due to overweight and obesity in South-East Asia region, and 
overweight prevalence ranged from 8% to 30 % among males and 8% to 52% among 
females10. Waist circumference is an approximate index of intra-abdominal fat mass and 
which is a risk of NCDs 38. Previous studies in Myanmar from 2003 and 2009 showed that the 
prevalence of obesity (BMI ≥ 30Kg/m2) was 0.25% and 4.3% in males, and 0.8% and 8.4% in 
females respectively 23,24. 
 
1.5.7 Blood Glucose and Diabetes Mellitus 
Diabetes Mellitus (DM) is a chronic condition that occurs either when pancreas does not 
produce enough insulin or when the body cannot effectively use the insulin it produces 46.  
 
It was estimated that 347 million people in the world had diabetes mellitus in 2008 47. WHO 
predicted that DM prevalence has steadily increased globally, and that diabetes caused 1.3 
million deaths in 2008 10. Furthermore, more than 80% of diabetes deaths occur in the low 
and middle income countries 48. DM increases the risk of cardiovascular diseases, stroke, 
renal failure, neuropathy and retinopathy10,49,50. The prevalence of DM is increasing in the 
South-East Asia region, predominantly among urban residents 13.   
 
The prevalence of DM in Myanmar was about 2.5 % in 1995 and in 2000; and expected to 
increase to 3.2 % by the year 2015 13. A report from the 2003/04 STEP survey in Yangon 
region showed that the overall prevalence of DM was 12 % based on the standard oral glucose 
tolerance test (OGTT), and 13% for combined impaired fasting glycaemia (IFG) and impaired 
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glucose tolerance (IGT) 23. The prevalence of DM in urban area  (14 %) was double to that in 
rural area (7%) of Yangon region 23. 
 
1.5.8 Blood Lipids  
High blood cholesterol is one of the world major risk factors for cardiovascular diseases 51. 
WHO estimated that high blood cholesterol caused 2.6 million deaths (4.5% of total) 
worldwide and 29.7 million DALYs in 2004 10,25.  
 
High blood cholesterol increased the risk of cardiovascular diseases 51, and is responsible for a 
third of all ischemic heart disease worldwide 25. Studies from the South-East Asia region 
showed an increasing trend of blood cholesterol level52. It has been estimated that high 
cholesterol in the South-East Asia region causes 800,000 deaths every year 13. Diets high in 
saturated fat and low physical activity can cause high blood cholesterol25. It was estimated 
that reducing 10% of blood cholesterol by the age of 40 can lower 50% risk of ischemic heart 
disease at the age of 40, and 20% at the age of 70 53. 
 
Studies have showed that low levels of high density lipoprotein (HDL) was related to the 
development of the coronary heart disease (CHD) 54, high triglycerides (TG) was also 
independently associated with the development of the coronary heart disease 55. In 2008, the 
prevalence of high total cholesterol was 39% globally and 29% in the South-East Asian 
region10. The 2003/04 study in Yangon region detected 26.2% of high total cholesterol 
prevalence 23, and the prevalence of high total cholesterol and triglycerides were reported 
38.6% and 24.9% from a recent study of 4 townships in Myanmar in 2010 56.  
 
1.6 Cardiovascular Diseases  
Cardiovascular disease (CVDs), the greatest public health epidemic, is the number one killer 
in the modern world. The major CVDs include CHD, cerebrovascular disease, rheumatic heart 
disease and hypertension. Abnormal lipid profiles, hypertension, obesity, smoking, physical 
inactivity, harmful use of alcohol and unhealthy diets contribute to the development of the 
cardiovascular diseases 10,57. In 2008, CVDs caused 48% of global NCD deaths accounting for 
17 million deaths 13. About 80% of CVDs deaths occurred in the low- and middle-income 
countries 13. A previous study of CVDs in Yangon region reported that the prevalence of 
CHD, hypertension and rheumatic heart disease were 13.3%, 42.7% and 5.9% in urban areas 
and 8.5%, 57.9% and 19.1% in rural areas 58.  
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1.7 Rationale 
The NCDs burden can be reduced by controlling common modifiable risk factors. In 
Myanmar, the prevention and control of NCDs has been set up as the second priority 59, and 
the government aims to meet the UN commitment to NCDs 17. In this regard, the estimation 
of the burden of NCDs and their risk factors is essential in order to effectively implement 
public health policies.  
 
In 2003-2004 a WHO STEPs survey was undertaken in Yangon Division, and in 2009 a 
nationwide WHO STEPs survey. These studies provided information on risk behaviors such 
as tobacco use, alcohol consumption, and physical risk factors such as obesity and 
hypertension. Biochemical measurement such as blood glucose and lipids were also 
investigated in 2003-2004, but not in 2009 23,24. Thus, more studies on risk factors including 
biochemical measures are needed, to follow the development, and provide a baseline for 
preventive strategies. Due to increasing levels of blood cholesterol in South-East Asia region 
and scarce knowledge about abnormal lipid profiles in Myanmar, the associated factors of 
high lipid levels and other NCDs risk factors should be investigated. 
 
In order to improve the knowledge about NCD risk factors in Myanmar to help the planning 
of health policies, the present cross-sectional study was conducted.  
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1.8 Study Aim and Objectives 
 
1.8.1 Aim 
To estimate the prevalence of selected modifiable risk factors of non-communicable 
diseases and to investigate the association between hypercholesterolemia with selected 
socio-demographic factors and selected NCD risk factors among 25-74 year old 
citizens of urban area of Yangon Region, Myanmar. 
 
1.8.2 Objectives 
In 25-74 year old urban citizens of Yangon Region, Myanmar; 
(1) To estimate the prevalence, by gender and age groups, of the selected modifiable risk 
factors of non-communicable diseases such as smoking, alcohol consumption, 
physical inactivity, fruits and vegetables consumption, hypertension, overweight, 
obesity, high blood glucose and high blood cholesterol;   
(2) To investigate the association between hypercholesterolemia with selected socio 
demographics factors and selected NCD risk factors. 
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2. Population and Methods 
2.1 Study design 
A household-based cross-sectional study design was conducted with multi-stage cluster 
sampling. The methodology was in accordance with the WHO STEPs wise approach for the 
surveillance of major NCD risk factors (WHO, 2008) 60. All 3 STEPs were carried out.  
 
STEP (1) Questionnaire survey was based on socio-demographic characteristics, smoking, 
alcohol consumption, physical inactivity, fruits and vegetables consumption, history of 
hypertension and diabetes.  
STEP (2) Physical measurement included blood pressure, body height, weight, waist and hip 
circumference. 
STEP (3) Laboratory investigation was undertaken for fasting lipid profiles (total cholesterol 
(TC), triglycerides(TG), high-density lipoprotein (HDL)) and fasting blood glucose from the 
venous blood sample. 
 
2.2 Study Area 
The research took place in 6 urban townships of Yangon Region, Myanmar from 2nd 
September to 15th November 2013.Yangon region is located in the Lower part of Myanmar 
and its total population is estimated to be 5.7 million accounting for 10% of the entire 
nation61. The urban area of Yangon region is the smallest and the most developed region in 
Myanmar, and also the most densely populated area in Myanmar 3. 
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Figure 1:  Map of the Republic of the Union of Myanmar 
                       
                 Source of Map: From Myanmar Information Management Unit (MIMU) 2013 62                
 
2.3 Sampling method and study population 
Yangon region is made up of 45 townships (27 urban and 18 rural). Six urban townships were 
randomly selected. From each of the selected townships, five wards (ward is a part of a 
townships) were randomly selected (i.e. a total of 30 wards) (Available in the Appendix 1). 
From each ward, 26-27 households were randomly selected. One person from each household 
fulfilling the inclusion criteria was invited to participate. The participants answered a 
structured interview on socio-demographics and risk factors; anthropometric measurement 
and simple clinical examination were obtained. The next morning, they met for blood drawing 
in a nearby health facility or survey site. 
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Inclusion criteria 
25-74 year old citizens (both male and female) in urban area of Yangon Region had the equal 
chance of being invited. 
Exclusion criteria 
The exclusion criteria referred to mentally ill or mentally retarded patients, and people 
physically too ill to participate. The institutionalized people, Buddhist monks and nuns were 
also excluded from the study. 
 
2.3.1 Sample size 
For the calculation of the required sample size, WHO sample size calculator for STEP survey 
was used 60,63. http://www.who.int/chp/steps/resources/sampling/en/.  
Step (1) Initial calculation 
N = z 2 P (1-P)/e2 
Where N = sample size, z = statistics for α error 
P = estimated prevalence of major NCD risk factors  
e = margin of error 
Step (2) multiply by the design effect and number of ag-sex estimate 
            n =  N * Design effect* number of age-sex estimate 
Step (3) Adjust for expected non-response for final sample size 
              Final sample size= n*non-response rate 
Assumption: If we set the alpha error at 5%, z would be 1.96.  
Based on previous NCD studies in 2009, the prevalence of risk factors ranged between 1-
51.4% 24.  
A value of 50% was found to be the most conservative (i.e. yielding the highest sample size).  
For example Current smokeless tobacco user in males: 51.4%; obesity in males: 4.3% 
(according to 2009 national STEP survey)  
Based on the formula above with a response rate of 80% and design effect of 1, we required a 
sample size ranging from: 
Smokeless tobacco in male: 767 participants (i.e. 959 invited) 
Obesity in male: 126 participants (i.e. 158 invited) 
Taking the cluster sampling design into consideration, the sample size was as follows (design 
effect set at 1.5 according to recommendations from STEPS instruments 60. 
Smokeless tobacco in male: 1151 participants (i.e. 1439 invited) 
Obesity in male: 189 participants (i.e. 237 invited)  
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Most risk factors are less than 50%. Assuming that we decided to include 800 subjects that 
would give us fairly precise estimates for most of the risk factors. 
 
Figure 2 Sampling Process: Urban Yangon 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.2 Practical procedures of sampling  
2.3.2.1 Inviting people 
Personal invitation letter were sent to each household to attend the survey with the assistance 
of the street-leaders and the local authority. The invitation letter included the purpose of the 
study, date for testing and place. Information on physical measurement, venous blood 
investigation for fasting blood glucose and lipid profiles were included in the invitation and 
information letters. The letters were sent in Myanmar (Burmese) language. (Available in 
Appendix 2) 
 
 
18 rural townships 27 urban townships 
6 urban townships 
5 wards from each township 
(total 30 wards) 
 
26-27 households from each 
ward (total 804 households) 
 
1 from each household (804 invitees) 
758(94%) involved in STEP 1&2 
696(86%) participated all STEPs 
 
Yangon Region 
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2.3.2.2 Sampling procedures 
A multistage cluster sampling method was employed.  
 
First Stage: 6 urban townships were selected from 27 urban townships 
Firstly, a total of 6 townships were selected from 27 urban townships of Yangon region. We 
decided to invite 134 participants from each township with equal sex distribution.  
 
Second Stage: 30 wards were selected from 6 selected urban townships 
From each township, the list of wards was obtained and 5 wards were taken randomly. 
Advocacy meetings with local health authority and head of the ward and street-leaders were 
set - to describe details of the study and to strengthen cooperation.  
 
Third Stage: 26-27 household were selected from 30 selected wards 
In the third stage, sampling was conducted in the office of selected wards. Based on the 
data/map, a choice of 4 streets or blocks was taken using table of random numbers. Two 
streets/blocks were randomly selected for males and two streets/blocks for females. The next 
step was to select 6-7 households from each street/block through house number or compound 
number by using random multiple table. Altogether 26-27 households were randomly taken 
from the list of households for each selected ward.  
 
In some cases, there were two or more households in the same number, or new buildings with 
many flats, and different households shared the same roof. In such cases, a random selection 
was performed among household members. We excluded public buildings, hotels, big shops, 
religious buildings and schools during the selection process. 
 
Final Stage: one selected person from each household   
In the final stage, one eligible subject was randomly selected from the members of each 
selected household. When a household contained more than one eligible subject, a random 
selection was carried out among eligible household members. If no eligible participant was 
found in the chosen household, the selection was moved on to the next adjacent (particularly 
on the right). When the selected person refused, she/he was regarded as a non-respondent.  
Finally, we invited 804 participants (30 wards x 26-27Households) from urban areas (wards) 
with equal sex distribution (402 each). However, the final sample size included 758 (94%) for 
STEP (1) and (2). 696 (86%) participants completed all STEPs.  
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A total of 46 invitees were absent from 6 townships. Among them 39 refused to participate 
and 7 did not come to the meeting point.  Out of 758 participants, 62 participants did not 
come for the blood investigation. 3 pregnant women were included as participants; however, 
they were excluded from the analysis.  
No detailed interview or survey for the reason of refusal was conducted.  
 
2.4 Training of research assistants  
Four research assistants were recruited through the Myanmar Medical Association. A two-
days training and pre-test were conducted in the Myanmar Medical Association with the 
technical inputs from the Department of Medial Research (Lower Myanmar). The trainees 
were exposed to the methods of sampling, interpersonal communication, obtaining informed 
consent and a survey questionnaire on the first day. The second day of training was focused 
on interactive sessions to introduce data collection methods and correct measuring methods 
for all STEPs. Anthropometric measure, physiological measurement and laboratory tests were 
practiced and trained according to the standardized method of WHO guideline. 
 
Standardization of the instruments used in the field works were done before and during the 
training. The trained field researchers conducted a pretest comprising STEP 1 and STEP 2 of 
survey in Yangon region. Questionnaires were clarified further after the pretest. The trained 
field researchers underwent trial in practical skill after the clarification. 
 
2.5 Data collection 
Each day a total number of 26-27 participants were invited. After obtaining the consent from 
the invitee, face to face interview was conducted at the residence area of the participant. 
Effective health communication skills were used in asking questions about households and 
individuals. After the interview, anthropometrics measurement and simple clinical 
examination were conducted in a private area of the participant’s residence. Blood pressure 
and heart rate were measured followed by height, weight, waist and hip circumference 
measurement. Each and every participant was provided with appointment date and time 
(usually the next morning) for blood examination and was explained about the overnight 
fasting 10 hours before coming to the assembly site (mostly nearby administrative office or 
clinic or religious building). The participants also received a reminder phone call for 
overnight fasting by the fieldworkers in the evening. If the participants had not fasted, a new 
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appointment was set for another date and time. The field workers arranged home visits for 
blood testing for those having difficulty in attending the survey site.    
 
2.5.1 Questionnaire  
The questionnaire was adopted from the WHO STEPS Instrument version 2.1 and previously 
translated into Myanmar (Burmese) Language. Some of the questionnaires have been 
modified to adjust to the local context, for instance, regarding to marital status – the term 
‘partner’ is socially sensitive. Interviews were conducted using questionnaires among 758 
respondents.   
The questionnaires included socioeconomic status of the participants, the status of tobacco 
use, alcohol consumption, fruit and vegetable consumption, physical activity, history of 
hypertension and diabetes. (Available in Appendix 3) 
 
2.5.2 Anthropometrics measurements and simple clinical examination 
The anthropometrics measurement included body weight, height, waist and hip 
circumference.  
 
Since portable stadiometer was not available in Myanmar at the time of data collection, 
measuring tape was used to measure individual’s body height without foot wear and any head 
gear, taking in centimeter to the exact point of height (the nearest to 0.1 cm). Body weight 
was measured with a portable electronic weighing scale and noted in kilogram. The 
participants were requested to wear light clothes without footwear during weighing. 
 
Waist and hip circumference measurement were conducted in a private place with the 
measuring tape. Waist circumference was taken at midpoint between the lower margin of the 
last palpable rib and the top of the iliac crest (hip bone), in the standing position without 
clothing and directly over the skin, according to the WHO guideline 60. Exact point in 
centimeter was recorded. The hip circumference was taken in centimeter at maximum 
circumference over buttocks horizontally.   
 
Blood pressure was measured three times, 15 minutes after interviewing by using OMRON 
M6, automatic blood pressure monitor. WHO recommended OMRON M6 was validated 64 
and passed validation protocol 65. Following the WHO guideline, blood pressure was taken 
from the left arm, keeping the cuff at the same level as the heart during procedure with elbow 
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support. To attain correct measurement, no talk during procedure, emptying bladder, no 
coffee before and during the measurement were strictly followed. The universal cuff was 
used; however, appropriated cuffs were used when needed. The participants were allowed to 
rest for 3 minutes between each reading. The average of second and third readings of both 
systolic and diastolic pressure was calculated for feedbacks to participants and data analysis. 
 
 
2.5.3 Blood investigation 
Laboratory investigation included fasting blood glucose, total cholesterol, triglyceride and 
HDL.  
 
The participants were invited to the nearby health center or survey site in the morning for 
blood sample collection. Four milliliter of overnight fasting venous blood sample was drawn 
to measure serum total cholesterol, triglyceride, HDL and fasting plasma glucose. All of the 
participants were provided with breakfast (coffee/tea and snack) after blood sample 
collection.  
 
Blood samples were collected in the collection lipid tube and glucose tube containing fluoride 
separately in the cold boxes and transported to the National Health Laboratory, Yangon, a 
WHO reference laboratory in Myanmar, immediately for analysis. The results were reported 
the day after the test.  
 
Blood glucose concentration was measured by enzymatic reference method with hexokinase, 
using reagents of COBAS from Roche Diagnostics, Indianapolis, IN. Serum concentration of 
total cholesterol, triglycerides and HDL were determined by using enzymatic colorimetric test 
with reagents of COBAS from Roche Diagnostics, Indianapolis, IN. 
LDL concentration was calculated from Friedewald (1972) equation. 
 
LDL = TC – HDL – TG/ 2.17 (mmol/L) 
 
One male and one female participant refused to continue drawing blood during procedure, and 
we stopped immediately. In these cases, available amount of blood was used for fasting blood 
glucose.  
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2.6 Data Handling  
All the electronic and paper copies of the questionnaires were stored in the safe place of the 
principal investigator. Data was entered in the Epidata version 3.1, and transferred to SPSS 
for data cleaning and analysis. After data entry, the main copy was transferred to the memory 
stick to save from an unexpected damage. All information was handled with high 
confidentiality.  
 
2.7 Data management and analysis 
After each interview, the research assistant checked for completeness and consistency of the 
questionnaires. Data were coded by the principal investigator, double entered in Epidata 
software version 3.1. Data from Epidata 3.1 was transferred to the statistical package for 
Social scientists (SPSS) version 20 in order to clean and analyze.  
 
SPSS version 20 and Epi info 7 were used to calculate the descriptive and analytical statistics, 
in accordance with the WHO STEPS guidelines. Means, 95% confident interval (CI) and/or 
standard deviation (SD) were included in the descriptive analysis. Prevalence of NCDs risk 
factors were calculated in percentages with 95% confident interval. Age-standardized 
prevalence was calculated for the major risk factors by the direct standardization method with 
the WHO world standard population19.  
 
In the logistic regression analysis, some variables were recoded. Hypercholesterolemia was 
evaluated, and odds ratios (OR) with 95% confidence intervals (CI) and P-value were 
calculated using univariate and multivariate binary regression model.   
 
2.8 Ethics  
Approval for the present study was obtained from the Ministry of Health, Ethical committee 
from the Norwegian Regional Committees for Medical and Health Research Ethics (REK) 
and also from Department of Health, Myanmar. (Available in Appendix 4) The Regional 
Health Department of Yangon also granted the permission and provided supporting 
documents to the research team to conduct the present study properly.   
 
At the community level, the principal investigator contacted with both the township medical 
officers and the township administrators of each township to introduce the research project, 
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the purpose, the methods and content of investigation. The research team also obtained 
permission from the township health departments and local authorities. Verbal and written 
consents (available in Appendix 5) were obtained from each participant after explaining the 
purpose, method and procedures of the study. Awareness for their right to withdrawal from 
the study at any time without reprisal was ensured to every individual. The interview was 
done at the places where privacy was ensured. 
 
Utmost care was provided to avoid injury and infection to the participants during the venous 
blood drawing. The disposable sterile syringes and needles instruments were utilized and 
disinfection was carried out with strictness. If a participant suffered from injury or infection 
that was directly caused by blood drawing or participating in the study, the investigator would 
arrange for treatment and care in clinic or hospital by personal obligation. No injury was 
reported during blood investigation throughout the survey. All information of subject’s 
physical and mental integrity on the personality was handled with strict confidentially.  
2.9 Funding 
The research funding was provided by the NORHED Project of “Health and Sustainable 
Development in Myanmar (MY-NORTH)”.    
2.10 Feedback to the respondents 
Confidentiality of the test results was maintained and all the respondents were provided with 
the overview results from the physical examination and blood investigation. (The feedback 
form is available at Appendix 6) 
 
2.11     Variables 
Age and Education 
Age was defined as the completed year of age. Education was divided into seven categories; 
no formal school, less than primary school, primary school completed, secondary school 
completed, high school completed, college/university and post-graduate degree, and also the 
total years of education. In the regression analysis, education was regrouped into three groups 
from seven former groups, such as primary level, secondary level and high level education. 
Primary level was defined as education level that was below the primary school completed. 
Secondary level was regrouped as the education level that completed secondary or high 
school education. High education was defined as university or post-graduate education. 
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Ethnic group 
Ethnic groups were divided into 8 major ethnic groups of Myanmar, namely Kachin, Kayar, 
Kayin, Chin, Mon, Burma, Rakhine and Shan. The rest were categorised as “Others”. 
 
Marital status 
In marital status, the term “partner or cohabiting” was removed from the categories since it 
was not socially acceptable and no such customs were practiced in Myanmar.  
 
Employment 
Employment status were classified into 9 categories; government employee, non-government 
employee, self-employed, non-paid, student, homemaker, retired, unemployed (able to work) 
and unemployed (unable to work). In the regression analysis, the employment status was 
regrouped into three groups; employed, unpaid and retired and unemployed. Employed group 
included the people who had paid-jobs. Volunteer, student and homemakers were in the 
unpaid groups. Retired and unemployed people made the last group.   
 
Income 
To identify status of the income, monthly household income was asked. The daily income was 
calculated and converted into USD (United State dollar) from Kyats (Myanmar currency). 
 
Tobacco use 
Tobacco consumption was assessed with several questions and show cards were used.  
Current smoker was defined as those currently smoked daily or less than daily. Current 
smokeless tobacco user was defined as those who currently used any smokeless tobacco such 
as snuff, chewing tobacco and betel quid. Current tobacco user was defined as those currently 
smoked and/or used smokeless tobacco daily or less than daily.  
 
Alcohol consumption  
Alcohol consumption was assessed with the standard drinking. According to the WHO 
guideline, one standard drink was defined as any drink containing approximately net 10 grams 
of pure alcohol 60. During data collection on alcohol consumption, show cards and tables were 
used to get an approximate amount of consumption.  
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Current drinker was those who consumed alcohol in the previous 30 days. Binge drinking was 
defined as consuming on one occasion 5 or more standard drinks for males and 4 or more 
standard drinks for females 60,66. 
 
Fruits and vegetables consumption 
Frequency of fruits and vegetable consumption was asked in order to assess the dietary 
pattern of the participant. Show cards were used to guide and identify the amount of serving 
during data collection. One standard serving was equivalent to approximately 80 grams 60. 
One serving of vegetable was defined as one plate (quarter-plate) of raw green leafy 
vegetables, or half cup (quarter-bowl) of cooked or chopped vegetables, or half-cup (quarter-
bowl) of vegetable juice or soup.  One serving of fruit was defined as one medium sized piece 
of fruit, for instance mango, apple or banana, or half cup (quarter-bowl) of cooked or chopped 
fruits, or half-cup (quarter-bowl) of fruits juice or soup.  
 
Physical activity  
Physical activities were categorized into 3 groups as high level physical activity, moderate 
level physical activity and low level physical activity by using standard metabolic equivalent 
of tasks (MET) based on WHO guidelines. One MET unit is defined as energy utilized by the 
body’s metabolism while sitting quietly in position, which is equal to 1 kcal/kg/hour 60. Total 
Physical activities were calculated with domain of MET units. MET value for vigorous 
activities of work and recreation is 8.0, for moderate activities of work, recreation like 
walking and jogging and transport is 4.0 60.   
High Physical activity: those who had at least 3 days of vigorous activity with minimum of 
1500 MET minutes per week OR who had 7 or more days of moderate activity with minimum 
3000 MET- minutes per week.  
Moderate Physical activity:  
A person who did not meet above mentioned criteria, but he/she were entitled the following 
criteria were classified as moderate physical activity.  
Those who had 3 or more days of vigorous-intensity activity of at least 20 minutes per day or 
who had 5 or more days of moderate-intensity activity at least 30 minutes per day OR  
5 or more days of any combination of walking, moderate- or vigorous intensity activities 
having a minimum of at least 600 MET-minutes per week 67. 
Low Physical activity: Those who did not meet the criteria for above mentioned groups were 
contained in the low physical activity group 60. 
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Hypertension 
Hypertension was defined as an average of systolic blood pressure (SBP) ≥140 mmHg and/ or 
diastolic blood pressure (DBP) ≥ 90 mmHg, and/or self-reported current anti-hypertensive 
treatment for hypertension within 2 weeks prior to the interview 60. 
Current use of anti-hypertensive drugs was recorded, as well as awareness of hypertension. 
Awareness of hypertension was defined as self-reported of a prior diagnosis by medical 
doctor or health workers. Treatment of hypertension was defined as the use of anti-
hypertensive drugs for hypertension prescribed by the medical doctors or health workers. 
Control of hypertension was regarded as SBP <140 and/or DBP <90 mmHg among those 
currently on treatment with a previous history of Hypertension. 
 
Anthropometry  
Body Mass index (BMI) was computed as weight in kilograms divided by height in meters 
squared (kg/m2).  
BMI= Body weight (kg): Body height (m) 2 
WHO defines underweight as ≤ 18.4 kg/m2, normal weight as 18.5-24.9 kg/m2, overweight as 
25-29.9 kg/m2 and obesity as ≥ 30 kg/m 246. 
Several studies showed that Asian people had the higher percentage of body fat than in white 
people of the same age, sex and BMI, therefore, the WHO expert consultation suggested that 
the WHO BMI cut off was not suitable for the Asian population 68. They identified the 
potential BMI cut off (overweight=23-27.5 kg/m2.Obese ≥27.5 kg/m2) for different Asian 
population, 68 although, some studies debated on that cut-points for Asian 69-72. 
In the present study, BMI was also classified according to the WHO BMI cut off for Asian – 
Underweight <18.5 kg/m2 , normal weight as 18.5-22.9 kg/m2, overweight as 23-27.5 kg/m2 
and obesity as ≥ 27.5 kg/m 268. 
The central obesity for Asian was defined as men with waist circumference (WC) ≥ 90 cm, 
and the women with (WC) ≥ 80 cm according to the WHO guideline 73. Waist-to-hip ratio 
(WHR) was defined as the ratio of the circumference of the waist to that of the hips 74. 
 
High blood glucose/ Diabetes 
Diabetes Mellitus (DM) was defined as a fasting blood glucose level of 7 ≥ mmol/L 75. 
Awareness of DM was defined as a prior diagnosis by a medical doctor or health workers.  
Treatment of DM was defined as on the medication for Diabetes Mellitus prescribed by a 
medical doctors or health workers. 
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Control of DM was regarded as a fasting blood glucose level of < 7mmol/L among those 
currently on treatment with a previous history of DM. 
 
Lipid profiles 
Laboratory results for lipid profiles were assessed based on the WHO category in Table (1). 
 
Table 1. Lipid profiles indicators (WHO) 60 
Lipid profiles Normal Moderate High 
Total Cholesterol <5.0 mmol/L 5.0-6.1 mmol/L ≥6.2 mmol/L 
Triglycerides <2.0 mmol/L  ≥2.0 mmol/L 
HDL Low: Male:<1.03 mmol/L, Female: <1.29 )mmol/L 
 
Hypercholesterolemia was also determined as more than 5.17 mmol/L of total cholesterol 
level according to the abnormal lipid profile criteria in the report of National Cholesterol 
Education Programme (NCEP) 19. LDL was defined as normal <4.13 mmol/L, at risk 4.13-4.9 
mmol/L and increased >4.91 mmol/L based on NCEP report 19. 
 
2.12 The Framingham coronary heart disease (CHD) prediction 
The Framingham risk score is to estimate the 10 year risk of developing coronary heart 
disease 57. It is an gender-specific algorithm and based on the age, total cholesterol, HDL, 
systolic blood pressure and diastolic blood pressure, diabetes mellitus and smoking57. The low 
risk is less than 10% chance, intermediate risk is 10-20% chance and high risk is more than 20 
% chance of developing coronary heart diseases 76. The prediction of the coronary heart 
disease was computed with moderate and high 10 years risk (i.e more than 10 % of chance).  
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3. RESULTS 
3.1 Socio-demographic characteristics 
The Socio-demographic characteristics of the study population are described in Table (2). The 
mean age of the participants was 48.7 years with standard deviation 13.2 (Male 49.8±13.8 and 
Female 47.5±12.4).  
 
The mean years of education was 10.8 ± 3.8 (male 10.8 ±3.8 and female 9.7±4.3). 
More women than men attained less education than Primary school. Most of the female were 
homemakers, i.e housework (50 %), while most male were self-employed (45%). 9% of the 
participants did not have occupation although they were able to work. The unemployment rate 
was 10 % with no pattern in genders.  
 
79% of male and 70 % of female were married and less than 1 % was divorced.  
More than 40% of the population lived under the poverty line (less than 2USD/day), and 11% 
of males and 15 % of females, respectively, lived in extreme poverty (less than 1 USD/day). 
Only 15 % earned more than 5 USD/day.  
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Table 2. Socio-demographics characteristics among 25-74 year urban citizens of Yangon 
Region, Myanmar 
  Male (n=376) Female (n=379) Total (n=755)  Number    % Number    % Number    % 
Age(Years) Mean ± SD 
Age(Years) 49.8±13.8 47.5±12.4 48.7±13.2 
 25-34 75 19.9 67 17.7 142 18.8 
 35-44 61 16.2 99 26.1 160 21.2 
 45-54 79 21.0 92 24.3 171 22.6 
 55-64 96 25.5 82 21.6 178 23.6 
 65-74 65 17.3 39 10.3 104 13.8 
 
Education (Years) Mean ± SD 10.8±3.8 9.7±4.3 10.2±4.1 
Highest Education       
 No formal school 7 1.9 13 3.4 20 2.6 
 Less than Primary school 10 2.7 25 6.6 35 4.6 
 Primary school completed 74 19.7 93 24.5 167 22.1 
 Secondary school completed 98 26.1 78 20.6 176 23.3 
 High school completed 87 23.1 70 18.5 157 20.8 
 College/University completed 
93 24.7 92 24.3 185 24.5 
 Post graduate degree 7 1.9 8 2.1 15 2.0 
Occupation       
 Government employee 27 7.2 13 3.4 40 5.3 
 Non-government employee 53 14.1 15 4.0 68 9.0 
 self-employed 170 45.2 104 27.4 274 36.3 
 Non-paid 14 3.7 2 0.5 16 2.1 
 Student 1 0.3 0 0 1 0.1 
 Homemaker 0 0 192 50.3 190 25.2 
 Retired 71 18.9 17 4.5 88 11.7 
 Unemployed (able to work) 34 9.0 32 8.4 66 8.7 
 Unemployed (unable to work) 
6 1.6 6 1.6 12 1.6 
Marital status       
 Never married 60 16.0 56 14.8 116 15.4 
 Currently married 295 78.5 266 70.2 561 74.3 
 Separated 2 0.5 5 1.3 7 0.9 
 Divorced 1 0.3 5 1.3 6 0.8 
 Widowed 18 4.8 47 12.4 65 8.6 
Income Status (MMK*)       
 Less than 1 USD per day 40 10.6 56 14.8 96 12.7 
 1-2 USD per day 112 29.8 111 29.3 223 29.5 
 >2 - 5 USD USD per day 136 36.2 123 32.5 259 34.3 
 more than 5 USD per day 57 15.2 53 14.0 110 14.6 
 Refused to answer 31 8.2 36 9.5 67 8.9 
*MMK : Myanmar Kyats (1 USD=953.8 MMK as of 05-11-2013) 
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3.2 Tobacco use  
The prevalence of smoking was more than 10 times higher in males (43%) than in females 
(4%). (Table 3)  Among younger males, the prevalence of smoking was the highest (57%), 
and among females the prevalence was highest in the older age groups (3-9%).  
 
 
Table 3. Current smokers by age and genders among 25-74 years old citizens of urban  
Yangon 
*Current smoker was defined as those currently smoked daily or less than daily.  
 
Table (4) presents the status of smokeless tobacco use. The prevalence of smokeless tobacco 
was 40 % among males and 16% among females, giving a total of 28 %. In the male 
population, the prevalence of smokeless tobacco consumption was highest among younger 
age groups, with the same pattern was observed among females. 
  
Table 4. Current smokeless tobacco users by age and genders among 25-74 years old  
citizens of urban Yangon 
* Current smokeless tobacco user was defined as those who currently used any smokeless tobacco such as snuff, chewing 
tobacco and betel quid. 
*Current smokers 
Age group 
(Years) 
Male Female Both Genders 
N % 95% CI N % 95% CI N % 95% CI 
25-34 75 57.3 (45.4-68.7) 67 0.0 - 142 30.3 (22.9-38.6) 
35-44 61 45.9 (33.1-59.2) 99 3.0 (0.6-8.6) 160 19.4 (13.6-26.4) 
45-54 79 57.0 (45.3-68.1) 92 3.3 (0.7-9.2) 171 28.1 (21.5-35.4) 
55-64 96 36.5 (26.8-46.9) 82 8.5 (3.5-16.8) 178 23.6 (17.6-30.5) 
65-74 65 18.5 (9.9-30.0) 39 2.6 (0.1-13.5) 104 12.5 (6.8-20.4) 
Total 376 43.4 (38.3-48.5) 379 3.7 (2.1-6.3) 755 23.4 (20.5-26.7) 
*Current Smokeless Tobacco Users 
Age Group 
(Years) 
Male Female Both Genders 
N % 95% CI N % 95% CI N % 95% CI 
25-34 75 54.7 (42.8-66.2) 67 16.4 (8.5-27.5) 142 36.6 (28.7-45.1) 
35-44 61 50.8 (37.7-63.8) 99 15.2 (8.7-23.8) 160 28.8 (21.2-36.4) 
45-54 79 46.8 (35.5-58.4) 92 19.6 (12.0-29.1) 171 32.2 (25.2-39.7) 
55-64 96 30.2 (21.2-40.4) 82 11.0 (5.1-19.8) 178 21.4 (15.6-28.1) 
65-74 65 21.5 (12.3-33.5) 39 15.4 (5.9-30.5) 104 19.2 (12.2-28.1) 
Total 376 40.4 (35.5-45.6) 379 15.6 (12.1-19.7) 755 27.9 (24.8-31.3) 
30
Table (5) shows the prevalence of tobacco use, cigarette smoking or smokeless tobacco, 
indicating a prevalence of 64% in males and 18% in females. The prevalence was highest in 
the age groups 25 to 54 in males (75-79%).  
 
Table 5. Current tobacco users (both smoke and smokeless) by age and genders among 
25-74 years old citizens of urban Yangon 
 * Current tobacco user was defined as those who currently smoked and/or used smokeless tobacco daily or less than daily.  
 
3.3 Alcohol consumption   
The overall prevalence of the current drinkers, binge drinkers and lifetime abstainers were 
14%, 6% and 65% (not shown in Tables). Table (6) indicates that the current drinking pattern 
was higher in the younger age groups. The current drinking pattern was almost 50% in the 
youngest age group (25-34 years). Alcohol consumption was low among females, 89% was 
lifetime abstainers and only 1% was current drinkers.  
 
 Table 6. Alcohol consumption status of males by age among 25-74 years old citizens of 
urban Yangon 
*Current Tobacco Users 
Age Group 
(Years) 
Male Female Both Genders 
N % 95% CI N % 95% CI N % 95% CI 
25-34 75 77.3 (66.2-86.2) 67 16.4 (8.5-27.5) 142 48.6 (40.1-57.1) 
35-44 61 75.4 (62.7-85.5) 99 17.2 (10.3-26.1) 160 39.4 (39.8-47.4) 
45-54 79 78.5 (67.8-86.9) 92 20.7 (12.9-30.4) 171 47.4 (39.7-55.1) 
55-64 96 54.2 (43.7-64.4) 82 19.5 (11.6-29.7) 178 38.2 (31.0-45.8) 
65-74 65 36.9 (25.3-49.8) 39 15.4 (5.9-30.5) 104 28.8 (20.4-38.6) 
Total 376 64.4 (59.3-69.2) 379 18.2 (14.5-22.5) 755 41.2 (37.7-44.8) 
Alcohol Consumption status among Males 
Age  
group 
(Years) 
N 
Current drinkers 
(past 30 days) 
Drank in past 
12 months 
Past 12 months 
abstainer 
Lifetime  
abstainers 
% 95% CI % 95% CI % 95% CI % 95% CI 
25-34 142 49.3 (37.6-61.2) 6.7 (2.2-14.9) 12.0 (5.6-21.6) 32.0 (21.7-43.8) 
35-44 160 31.1 (20.0-44.3) 18.0 (9.4-30.0) 23.0 (13.2-35.5) 27.9 (17.2-40.8) 
45-54 171 30.4 (20.5-41.8) 13.9 (7.2-23.6) 21.5 (13.1-32.2) 34.2 (23.8-45.7) 
55-64 178 16.7 (9.8-25.7) 7.3 (3.0-14.5) 33.3 (24.0-43.7) 42.7 (32.6-53.2) 
65-74 104 7.7 (2.5-17.1) 6.2 (1.7-15.0) 21.5 (12.3-33.5) 64.6 (51.8-76.1) 
Total 755 26.9 (22.5-31.7) 10.1 (7.3-13.7) 22.9 (18.8-27.5) 40.2 (35.2-45.3) 
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Table 7. Alcohol consumption status of females by age among 25-74 years old citizens of 
urban Yangon 
 
 
3.4 Fruits and vegetables consumption   
The average number of days consuming fruits in a week was 3.1 days in total (3.0 days in 
males and 3.2 days in females). The average number of days consuming vegetables per week 
was 5.4 days (5.3 days among males and 5.5 days among females). The overall mean number 
of serving fruit and/or vegetables per day was 3.1 days (3.2 days in males and 3.0 days in 
females) (not shown in Tables). Table (8) shows that 82 % of the respondents consumed less 
than the recommended five servings of fruits and vegetables on average per day. 
Consumption of fruits and vegetables was higher among males than females. 
 
 
Table 8. Less than five servings of fruits and/or vegetables on an average per day by age 
and genders among 25-74 years old citizens of urban Yangon 
Alcohol Consumption status among females 
Age 
group 
(Years) 
N 
Current 
Drinkers 
Drank in past 
12 months 
Past 12 months 
abstainer 
Lifetime 
abstainers 
% 95% CI % 95% CI % 95% CI % 95% CI 
25-34 67 1.5 (0.04-8.0) 6.0 (1.7-14.6) 13.4 (6.3-24.0) 79.1 (67.4-88.1) 
35-44 99 1.0 (0.03-5.5) 2.0 (0.3-7.1) 9.1 (4.2-16.6) 87.9 (79.8-93.6) 
45-54 92 2.2 (0.3-7.6) 2.2 (0.3-7.6) 2.2 (0.3-7.6) 93.5 (86.3-97.6) 
55-64 82 0.0 - 1.2 (0.03-6.6) 4.9 (1.3-12.0) 93.9 (86.3-98.0) 
65-74 39 2.6 (0.1-13.5) 0 - 7.7 (1.6-20.9) 89.7 (75.8-97.1) 
Total 379 1.3 (0.5-3.2) 2.4 (1.2-4.6) 7.1 (4.8-10.3) 89.2 (85.5-92.0) 
Less than five servings of fruits and/or vegetables on an average per day 
Age Group 
(Years) 
Male Female Both Genders 
N % 95% CI N % 95% CI N % 95% CI 
25-34 75 86.7 (76.8-93.4) 67 86.6 (76.0-93.7) 142 86.6 (79.9-91.8) 
35-44 61 78.7 (66.3-88.1) 99 81.8 (72.8-88.9) 160 80.6 (73.6-86.4) 
45-54 79 81.0 (70.6-89.0) 92 87.0 (78.3-93.1) 171 84.2 (77.9-89.3) 
55-64 96 78.1 (68.5-85.9) 82 81.7 (71.6-89.4) 178 79.8 (73.1-85.4) 
65-74 65 75.4 (63.1-85.2) 39 87.2 (72.6-95.7) 104 79.8 (70.8-87.0) 
Total 376 80.1 (75.6-83.9) 379 84.4 (80.3-87.9) 755 82.3 (79.3-84.9) 
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3.5 Physical activity   
Table (9-11) presents the level of physical activity. Generally, the majority of the people were 
engaged in moderate and high level physical activity.  The highest percentage of high physical 
activity was detected in the youngest age-groups and declined with increasing age, 14 % were 
engaged in low physical activity. More males had low physical activity compared with 
females. 
 
Table 9. Level of physical activity by age among 25-74 years old citizens of urban 
Yangon 
Level of total physical activity  
Age 
group 
Years 
N 
Low Physical 
activity* 
Moderate Physical 
activity** 
High physical 
activity*** 
% 95% CI % 95% CI % 95% CI 
25-34 142 9.9 (5.5-15.0) 16.2 (10.6-23.3) 73.9 (65.9-80.9) 
35-44 160 10.6 (6.3-16.5) 20.6 (14.6-27.7) 68.8 (61.0-75.8) 
45-54 171 8.8 (5.0-14.1) 18.1 (12.7-24.7) 73.1 (65.8-79.6) 
55-64 178 16.3 (11.2-22.6) 27.5 (21.1-34.7) 56.2 (48.6-63.6) 
65-74 104 26.0 (17.9-35.5) 37.5 (28.2-47.5) 36.5 (27.3-46.6) 
Total 755 13.5 (11.2-16.2) 23.2 (20.3-26.4) 63.3 (59.8-66.7) 
*Low physical activity <600MET minutes per week, **Moderate physical activity: vigorous activity >3 days at least 20 
minutes, or moderate activity > 5 days at least 30 minutes per day, or > 5 day of any combination who had > 600 MET 
minutes per week ***High physical activity: at least 3 days of vigorous activity> 1500 MET minutes per week or moderate 
activity >7 with >3000 MET- minutes per week.  
 
 
Table 10. Level of physical activity of males by age among 25-74 years old citizens of 
urban Yangon 
*Low physical activity <600MET minutes per week, **Moderate physical activity: vigorous activity >3 days at least 20 
minutes, or moderate activity > 5 days at least 30 minutes per day, or > 5 day of any combination who had > 600 MET 
minutes per week ***High physical activity: at least 3 days of vigorous activity> 1500 MET minutes per week or moderate 
activity >7 with >3000 MET- minutes per week.  
Level of total physical activity among Males 
Age 
group 
Years 
N 
Low Physical 
activity* 
Moderate Physical 
activity** 
High physical 
activity*** 
% 95% CI % 95% CI % 95% CI 
25-34 75 6.7 (2.2-14.9) 14.7 (7.6-24.7) 78.7 (67.7-87.3) 
35-44 61 14.8 (7.0-26.2) 29.5 (18.5-42.6) 55.7 (42.5-68.5) 
45-54 79 12.7 (6.3-22.1) 24.1 (15.1-35.0) 63.3 (51.7-73.9) 
55-64 96 19.8 (12.4-29.2) 34.4 (25.0-44.8) 45.8 (35.6-56.3) 
65-74 65 23.1 (13.5-35.2) 40.0 (28.0-52.9) 36.9 (25.3-49.8) 
Total 376 15.4 (12.0-19.6) 28.5 (24.0-33.4) 56.1 (50.9-61.2) 
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Table 11. Level of physical activity of females by age among 25-74 years old citizens of 
urban Yangon 
Level of total physical activity among Females 
Age 
group 
Years 
N 
Low Physical 
activity* 
Moderate Physical 
activity** 
High physical 
activity*** 
% 95% CI % 95% CI % 95% CI 
25-34 67 13.4 (6.3-24.0) 17.9 (9.6-29.2) 68.7 (56.2-79.4) 
35-44 99 8.1 (3.6-15.3) 15.2 (8.7-23.8) 76.8 (67.2-84.7) 
45-54 92 5.4 (1.8-12.2) 13.0 (6.9-21.7) 81.5 (72.1-88.9) 
55-64 82 12.2 (6.0-21.3) 19.5 (11.6-29.7) 68.3 (57.1-78.1) 
65-74 39 30.8 (17.0-47.6) 33.3 (19.1-50.2) 35.9 (21.2-52.8) 
Total 379 11.6 (8.7-15.4) 17.9 (14.3-22.3) 70.4 (65.5-74.9) 
*Low physical activity <600MET minutes per week, **Moderate physical activity: vigorous activity >3 days at least 20 
minutes, or moderate activity > 5 days at least 30 minutes per day, or > 5 day of any combination who had > 600 MET 
minutes per week ***High physical activity: at least 3 days of vigorous activity> 1500 MET minutes per week or moderate 
activity >7 with >3000 MET- minutes per week.  
 
3.6 Body mass index (BMI) 
BMI classification is shown in the Tables (12-15). Based on the WHO classification, the 
results revealed that 44 % of the participants were overweight and obesity, 53% and 35% 
were females and males respectively (Table 12).  The highest prevalence of overweight and 
obesity was observed in the 35-54 years age groups. The prevalence of underweight was more 
than 2 times higher in males compared to females. 
Based on the BMI classification for Asian (Table 15), the prevalence of overweight and 
obesity was 61 %, the highest prevalence (70%) was observed in 45-54 year age-groups.  
 
Table 12. BMI WHO standard Classification by age among 25-74 years old citizens of 
urban Yangon 
BMI Classification 
Age 
Group 
(years) 
N 
Underweight Normal Overweight Obesity 
% 95%CI % 95%CI % 95%CI % 95%CI 
25-34 142 10.6 (6.0-16.8) 61.3 (52.7-69.3) 21.8 (15.3-29.5) 6.3 (2.9-11.7) 
35-44 160 6.3 (3.0-11.2) 44.4 (36.5-52.4) 36.3 (28.8-44.2) 13.1 (8.3-19.4) 
45-54 171 3.5 (1.3-7.5) 42.1 (34.6-49.9) 37.4 (30.2-45.1) 17.0 (11.7-23.4) 
55-64 178 5.6 (2.7-10.1) 51.7 (44.1-59.2) 29.2 (22.7-36.5) 13.5 (8.8-19.4) 
65-74 104 7.7 (3.4-14.6) 50.0 (40.0-60.0) 25.0 (17.0-34.5) 17.3 (10.6-26.0) 
Total 755 6.5 (4.9-8.6) 49.5 (45.9-53.2) 30.6 (27.4-3.0) 13.4 (11.1-16.1) 
BMI: underweight ≤ 18.4 kg/m2, normal weight =18.5-24.9 kg/m2, overweight =25-29.9 kg/m2 and obesity as ≥ 30 kg/m2. 
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Table 13. BMI WHO standard Classification of males by age among 25-74 years old 
citizens of urban Yangon 
 
Age  
Group 
 years 
N 
Underweight Normal Overweight Obesity 
% 95%CI % 95%CI % 95%CI % 95%CI 
25-34 75 13.3 (6.6-23.2) 64.0 (52.1-74.8) 20.0 (11.7-30.8) 2.7 (0.3-9.3) 
35-44 61 11.5 (4.7-22.2) 54.1 (40.9-66.9) 27.9 (17.2-40.8) 6.6 (1.8-16.0) 
45-54 79 5.1 (1.4-12.5) 45.6 (34.3-57.2) 41.8 (30.8-53.4) 7.6 (2.8-15.8) 
55-64 96 7.3 (3.0-14.5) 60.4 (49.9-70.3) 25.0 (16.7-34.9) 7.3 (3.0-14.5) 
65-74 65 10.8 (4.4-20.9) 52.3 (39.5-64.9) 21.5 (12.3-33.5) 15.4 (7.6-26.5) 
Total 376 9.3 (6.7-12.8) 55.6 (50.4-60.7) 27.4 (23.0-32.3) 7.7 (5.3-11.0) 
BMI: underweight ≤ 18.4 kg/m2, normal weight =18.5-24.9 kg/m2, overweight =25-29.9 kg/m2 and obesity as ≥ 30 kg/m2. 
 
Table 14. BMI WHO standard Classification of females by age among 25-74 years old 
citizens of urban Yangon 
Age 
 Group  
years 
N 
Underweight Normal Overweight Obesity 
% 95%CI % 95%CI % 95%CI % 95%CI 
25-34 67 7.5 (2.5-16.6) 58.2 (45.5-70.2) 23.9 (14.3-35.9) 10.4 (4.3-20.4) 
35-44 99 3.0 (0.6-8.6) 38.4 (28.8-48.7) 41.4 (31.6-51.8) 17.2 (10.3-26.1) 
45-54 92 2.2 (0.3-7.6) 39.1 (29.1-49.9) 33.7 (24.2-44.3) 25.0 (16.6-35.1) 
55-64 82 3.7 (0.8-10.3) 41.5 (30.7-52.9) 34.1 (24.0-45.5) 20.7 (12.6-31.1) 
65-74 39 2.6 (0.1-13.5) 46.2 (30.1-62.8) 30.8 (17.0-47.6) 20.5 (9.3-36.5) 
Total 379 3.7 (2.1-6.3) 43.5 (38.5-48.7) 33.8 (29.1-38.8) 19.0 (15.3-23.4) 
BMI: underweight ≤ 18.4 kg/m2, normal weight =18.5-24.9 kg/m2, overweight =25-29.9 kg/m2 and obesity as ≥ 30 kg/m2. 
 
 
 Table 15. BMI Classification for Asian by age among 25-74 years old citizens of urban 
Yangon 
Underweight <18.5 kg/m2 , normal weight=18.5-22.9 kg/m2, overweight=23-27.5 kg/m2 and obesity  ≥ 27.5 kg/m2 
Age 
Group 
years 
N 
Underweight Normal Overweight Obesity 
% 95%CI % 95%CI % 95%CI % 95%CI 
25-34 142 10.0 (5.6-16.2) 45.7 (37.3-54.3) 30.0 (22.6-38.3) 14.3 (9.0-21.2) 
35-44 160 5.7 (2.7-10.6) 28.7 (21.7-36.4) 40.1 (32.4-48.2) 25.5 (18.9-33.0) 
45-54 171 3.6 (1.3-7.6) 26.6 (20.1-34.0) 38.5 (31.1-46.2) 31.4 (24.5-38.9) 
55-64 178 5.7 (2.8-10.3) 31.0 (24.3-38.5) 39.1 (31.8-46.8) 24.1 (18.0-31.2) 
65-74 104 7.8 (3.5-14.9) 32.4 (23.4-42.3) 36.3 (27.0-46.4) 23.5 (15.7-33.0) 
Total 755 6.3 (4.7-8.4) 32.5 (29.1-36.0) 37.1 (33.6-40.7) 24.1 (21.1-27.4) 
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3.7 Waist circumference (WC) and hip circumference  
The prevalence of central obesity (Males: WC ≥ 90cm and Females: WC ≥ 80 cm) was 29 % 
in men and 55 % in women. On an average, the mean waist-to-hip ratio was 0.89 in men and 
0.83 in women (not shown in Tables). Tables (16-17) present the mean waist circumference 
and hip circumference by age groups and gender. The mean waist circumference was 
significantly lower in youngest age group in comparison with other age-groups. The highest 
mean hip circumference was found among 45-54 year age-groups in males. 
 
Table 16. Mean waist circumference by age and genders among 25-74 years old citizens 
of urban Yangon  
 *Mean in Centimeter.  
 
 
 
 
Table 17. Mean hip circumference by age and genders among 25-74 years old citizens of 
urban Yangon  
*Mean in Centimeter.  
 
 
Age 
Group 
Years 
Mean Waist circumference  
Male Female Both Genders 
N Mean 95% CI N Mean 95% CI N Mean 95% CI 
25-34 75 76.6 (73.9-79.2) 67 73.7 (71.3-76.0) 142 75.2 (73.4-77.0) 
35-44 61 83.2 (80.1-86.4) 99 80.8 (78.7-82.9) 160 81.7 (79.9-83.5) 
45-54 79 85.6 (83.3-88.0) 92 84.8 (82.4-87.3) 171 85.1 (83.4-86.9) 
55-64 96 84.8 (82.6-87.1) 82 84.7 (82.3-87.1) 178 84.7 (83.1-86.4) 
65-74 65 85.2 (82.3-88.0) 39 86.1 (82.5-89.7) 104 85.4 (83.3-87.7) 
Total 376 83.1 (82.0-84.3) 379 81.9 (80.7-83.1) 755 82.5 (81.7-83.4) 
Age 
Group 
Years 
Mean Hip circumference  
Male Female Both Genders 
N Mean 95% CI N Mean 95% CI N Mean 95% CI 
25-34 75 90.0 (88.2-91.9) 67 94.3 (92.3-96.4) 142 75.2 (73.4-77.0) 
35-44 61 93.4 (91.0-95.7) 99 98.8 (96.9-100.8) 160 81.7 (79.9-83.5) 
45-54 79 95.9 (93.8-97.9) 92 100.4 (97.9-102.9) 171 85.1 (83.4-86.9) 
55-64 96 93.8 (91.8-95.7) 82 99.3 (97.0-101.7) 178 84.7 (83.1-86.4) 
65-74 65 94.7 (92.2-97.2) 39 98.9 (95.8-101.9) 104 85.4 (83.3-87.7) 
Total 376 93.6 (92.6-94.5) 379 94.3 (92.3-96.4) 755 96.1 (95.3-96.8) 
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3.8 Blood pressure  
The prevalence of hypertension was 48% with no difference between genders (Table 18). The 
prevalence of hypertension increased with increasing age. The highest prevalence (76%) was 
observed among the oldest age group. About one-third of the study population had the history 
of hypertension (29 % in males and 37% in females (not shown in Tables). The mean systolic 
blood pressure was 132.0 mmHg (133.6 in males and 130.0 in females) and the mean diastolic 
blood pressure was 82.0 mmHg (82.6 in males and 81.4 in females)(not shown in Tables). 
 
 Table 18. Hypertension and self-reported hypertension by age and genders among 25-
74 years old citizens of urban Yangon 
Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg and/ or diastolic blood pressure (DBP) ≥90 mmHg, 
and/or self-reported current anti-hypertensive treatment for hypertension within 2 weeks prior to the interview. 
 
Table (19) presents the blood pressure status according to the awareness, treatment and 
control. Among people with hypertension, 68 % were aware of their diagnosis; 28 % were 
controlled by anti-hypertensive drugs.  43% of previously diagnosed respondents did not take 
medication, of whom, 46% were males and 42% were females. With regard to gender, 
awareness, taking anti-hypertensive treatment and situation being controlled was higher in 
females compared to males.  
 
 
 
 
 
 
 
 
Age Group 
(Years) 
Male Female Both Genders 
n % 95% CI n % 95% CI n % 95% CI 
25-34 75 18.7 (10.6-29.3) 67 9.0 (3.4-18.5) 142 14.1 (8.8-20.9) 
35-44 61 39.3 (27.1-52.7) 99 39.4 (29.7-49.) 160 39.4 (31.8-47.4) 
45-54 79 50.6 (39.1-62.1) 92 54.3 (43.6-64.8) 171 52.6 (44.9-60.3) 
55-64 96 58.3 (47.8-68.3) 82 68.3 (57.1-78.1) 178 62.9 (55.4-70.0) 
65-74 65 72.3 (59.8-82.7) 39 82.1 (66.5-92.5) 104 76.0 (66.6-83.8) 
Total 376 48.1 (43.0-53.3) 379 48.3 (43.1-53.4) 755 48.2 (44.6-51.8) 
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Table 19. Prevalence of hypertension, its awareness, treatment and control by genders 
among 25-74 years old citizens of urban Yangon 
Raised blood pressure was defined as SBP ≥140 mmHg and/ or DBP ≥90 mmHg.  
Awareness of hypertension was defined as self-reported of a prior diagnosis by medical doctor or health workers. 
Treatment of hypertension was defined as the use of anti-hypertensive drugs for hypertension within 2 weeks prescribed by 
the medical doctors or health workers. 
Control of hypertension was regarded as SBP<140 and/or DBP<90 mmHg among those currently on treatment with a 
previous history of Hypertension. 
 
 3.9 Fasting blood glucose  
Mean fasting blood glucose was 5.9 mmol/L ±1.9 (95%CI:5.8-6.1 mmol/L), and stratification 
by genders showed no significant difference. The highest mean value (6.9 mmol/L) was found 
among 55-64 males (not shown in Tables). 
  
Regarding crude prevalence, Table (20) shows that the prevalence of Diabetes Mellitus was 
18% among both genders. Diabetes Mellitus increased with age in both genders. The oldest 
female group had the highest prevalence (43%).  
 
Table 20. Diabetes Mellitus and self-reported DM by age and genders among 25-74 
years old citizens of urban Yangon 
 
Diabetes Mellitus (DM) was defined as a fasting blood glucose level of 7 ≥ mmol/L and self-reported of a prior diagnosis  
by medical doctor or health workers. 
 
 
Raised blood 
pressure 
Awareness of 
Hypertension 
Current on 
Treatment Being controlled 
N % N % N % N % 
Male 
(n=376) 181 48.1 107 59.1 59 32.5 42 23.2 
Female 
(n=379) 183 48.3 141 77.0 83 45.3 60 32.7 
Total 
(n=755) 364 48.2 248 68.1 142 39.0 102 28.0 
Age 
Group 
(Years) 
Male Female Both Genders 
n DM 95%CI n DM 95%CI n DM 95%CI 
25-34 60 0.0 - 63 4.8 (1.0-13.3) 123 2.4 (0.5-7.0) 
35-44 54 1.9 (0.1-9.9) 91 11.0 (5.4-19.3) 145 7.6 (3.9-13.2) 
45-54 74 14.9 (7.7-25.0) 86 14.0 (7.4-23.1) 160 14.4 (9.3-20.8) 
55-64 87 33.3 (23.6-44.3) 79 29.1 (19.4-40.4) 166 31.3 (24.4-39.0) 
65-74 65 30.8 (19.9-43.5) 37 43.2 (27.1-60.5) 102 35.3 (26.1-45.4) 
Total 340 17.9 (14.1-22.5) 356 18.0 (14.2-22.5) 696 18.0 (15.2-21.1) 
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Table (21) presents the prevalence of diabetes and its awareness, treatment and control status. 
The percentage of awareness of diabetes was 63%, of them; about half was on medication 
with 22% being controlled. More females than males were aware of their diagnosis, however, 
there was no difference in being controlled status. 
 
Table 21. Prevalence of DM, its awareness, treatment and control by genders among 25-
74 years old citizens of urban Yangon 
 
Awareness of Diabetes Mellitus was defined as a prior diagnosis by medical doctor or health workers.  
Treatment of DM was defined as on the medication of DM prescribed by the medical doctors or health workers. 
Control of DM was regarded as a fasting blood glucose level of < 7mmol/L among those currently on treatment with a 
previous history of DM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Raised FBS Awareness of  Diabetes 
Current on  
Treatment Being controlled 
N % N % N % N % 
Male 
(n=340) 61 17.9 33 54.0 27 44.2 13 21.3 
Female 
(n=356) 64 18.0 45 70.0 34 53.1 14 21.8 
Total 
(n=696) 125 18 78 62.4 61 48.8 27 21.6 
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3.10 Fasting Lipid Profiles   
The mean total cholesterol level was 5.43 mmol/L (5.49 mmol/L in males and 5.37 mmol/L in 
females) ( not shown in Tables). 
Table (22) displays the prevalence of the abnormal lipid values by genders and age-
standardized rate adjusted to the WHO world population. The prevalence of high total 
cholesterol ((≥6.2 mmol/L ) was 18.1% standardized adjusted to the WHO world population. 
When hypercholesterolemia was defined as ≥ 5.17 mmol/L of total cholesterol, the prevalence 
was 56.6 % (62.7 % in males and 50.7% in females). Furthermore, high triglycerides was 
prevalent at 22.0%, low HDL 59.7%, and finally high HDL 4.6%. 
  
 Table 22. Prevalence of abnormal lipid profiles by genders among 25-74 years old 
citizens of urban Yangon 
 
Blood Lipids 
Male 
(n=338) 
n(%) 
Female 
(n=353) 
n(%) 
Total 
(n=691) 
N(%) 
Age- 
standardized 
(WHO) 
Total Cholesterol     
    Normal(<5.0 mmol/L) 115(34.0) 164(46.5) 279(40.4) 44.3 
    Moderate(5.0-6.1 mmol/L) 151(44.7) 120(34.0) 271(39.2) 37.6 
    High(≥6.2 mmol/L) 72(21.3) 69(19.5) 141(20.4) 18.1 
Hypercholesterolemia (≥5.17 mmol/L) 212(62.7) 179(50.7) 391(56.6) 52.6 
Triglyceride     
    Normal(<2.0 mmol/L) 238(70.4) 284(80.5) 522(75.5) 78.0 
    High(≥2.0 mmol/L) 100(29.6) 69(19.5) 169(24.5) 22.0 
HDL     
    Normal(Male:≥1.03 ,Female ≥ 
1.29 )mmol/L 
224(66.3) 80(33.7) 304(44.0) 40.3 
    Low(Male:<1.03,Female <1.29 )mmol/L 114(22.7) 273(77.3) 387(56.0) 59.7 
LDL     
    Normal <4.13 mmol/L 227(82.0) 282(79.9) 559(80.9) 82.6 
    Medium  =4.13-4.9 mmol/L 49(14.5) 46(13) 95(12.6) 12.8 
    High     >4.91 mmol/L 12(3.2) 25(6.6) 37(4.9) 4.6 
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Table 23. The association between socio-demographic and selected risk factors and 
€hypercholesterolemia by binary logistic regression analysis 
Characteristics 
Univariate Analysis Multivariate Analysis 
cOR 95% CI P-value aOR 95% CI P-value 
Gender:      
Male  
Female 
 
Ref. 
0.61 
 
 
(0.45-0.83) 
 
 
0.001* 
 
Ref. 
0.79 
 
 
(0.45-1.16) 
 
 
  0.318 
Age:            
25-34   
 
Ref. 
   Ref. 
  
35-44 1.26 (0.77-2.05) 0.356 1.24 (0.72-2.14) 0.434 
45-54 2.43 (1.49-3.93) <0.001
* 2.41 (1.38-4.19) 0.002
* 
55-64 3.25 (2.00-5.30) <0.001
* 3.43 (1.86-6.33) <0.001
* 
65-74 2.89 (1.68-4.99) <0.001
* 3.45 (1.58-7.50) <0.001
* 
Education:  
Primary  
 
Ref. 
   
Ref. 
  
Middle 0.94 (0.66-1.35) 0.750 0.84 (0.56-1.28) 0.419 
Higher 0.71 (0.48-1.07) 0.098 0.60 (0.36-0.99) 0.049* 
Occupation :  
Employment  
 
Ref. 
   
Ref. 
  
Unpaid  1.04 (0.73-1.49) 0.827 1.17 (0.73-1.87) 0.513 
Retired and unemployment 1.43 (0.98-2.10) 0.067 0.92 (0.53-1.60) 0.769 
Income:  
<1USD per day  
 
Ref. 
   
Ref. 
  
1-2USD per day 0.76 (0.42-1.37) 0.361 0.93 (0.54-1.60) 0.796 
2-5 USD per day 0.58 (0.35-0.95) 0.029* 1.46 (0.84-2.53) 0.175 
>5 USD per day 0.80 (0.49-1.30) 0.374 2.47 (1.23-4.95)    0.011* 
Tobacco use:  
Non-user  
Tobacco user 
 
Ref. 
1.62 
 
 
(1.19-2.21) 
 
 
0.002* 
 
Ref. 
1.90 
 
 
(1.24-2.89) 
 
 
0.003* 
Alcohol :  
Non-user  
Current drinker 
 
Ref. 
1.20 
 
 
(0.77-1.88) 
 
 
0.426 
 
Ref. 
0.95 
 
 
(0.54-1.68) 
 
 
0.865 
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Fruits &Vegetables intake 
 ≥5 servings per day 
Less than 5 servings per day 
 
Ref. 
1.17 
 
 
(0.79-1.74) 
 
 
0.442 
 
Ref. 
1.35 
 
 
(0.87-2.11) 
 
 
0.182 
Physical activity: 
 ≥ 600 MET-minutes 
 
Ref. 
   
Ref. 
  
Low Physical activity 1.35 (0.86-2.14) 0.197 1.30 (0.76-2.24) 0.342 
BMI-   
normal  
 
Ref. 
   
Ref. 
  
Overweight and Obesity 1.28 (0.94-1.75) 0.123 1.38 (0.96-1.98) 0.086 
Underweight 0.85 (0.46-1.57) 0.595 0.75 (0.38-1.50) 0.416 
Hypertension-  
No 
 
Ref. 
   
Ref. 
  
Yes  1.59 (1.18-2.16) 0.003* 1.23 (0.84-1.79) 0.293 
Diabetes-  
No  
 
Ref. 
   
Ref. 
  
Yes 1.22 (0.82-1.83) 0.318 0.83 (0.52-1.34) 0.452 
€Hypercholesterolemia: total cholesterol ≥ 5.17 mmol/L, cOR, crude odd ratio, aOR, adjusted odd ratio,  
 
3.11 The association between socio-demographic and selected risk factors and 
hypercholesterolemia 
Table (23) presents the association between hypercholesterolemia and socio-demographic and 
selected risk factors of NCDs. In multiple regression analysis showed high age and tobacco-
use, and low education as compared with higher education, and low income as compared with 
high income of >5 USD per day were associated with hypercholesterolemia after adjusting for 
all variables in table. In separate analyses (not shown in Tables) using total cholesterol ≥ 5.0 
mmol/L as cut off, there were similar results as presented in the Table (23). 
According to the Nagelkerke R-square, the variance was 14%, i.e the included variables 
explained 14% of the variation in hypercholesterolemia.   
 
3.12 Combined NCD risk factors 
Based on the WHO STEPS methodology, the combined exposure of five common risk factors 
including current daily smokers, less than five serving of fruits and vegetables per day, low 
physical activity, overweight (BMI≥25 kg/m2 ), hypertension (SBP ≥ 140 and/or DBP ≥ 90 
mmHg or currently on treatment) was employed to determine population risk for non-
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communicable diseases 77. Table (24) shows the summary of the combined risks factors by 
genders. 3.3% of the population had no risk factors while 65% had 1-2 risk factors and 32 % 
had three or more risk factors.  
 
Table 24. Combined NCD risk factors by genders among 25-74 years old citizens of 
urban Yangon 
 Male Female Both Genders 
% 95% CI % 95% CI % 95% CI 
0 risk factor 2.4 (1.2-4.7) 4.2 (2.5-6.9) 3.3 (2.2-4.9) 
1-2 risk factors 64.6 (59.5-69.4) 65.4 (60.4-70.2) 65.0 (61.5-68.4) 
3-5 risk factors 33.0 (28.3-38.0) 30.3 (25.8-35.3) 31.7 (28.4-35.1) 
Current daily smokers, less than 5 serving of fruits and vegetables per day, low physical activity (<600 MET-minutes), 
overweight and obese (BMI≥25kg/m2), raised BP (SBP≥140 and/or DBP≥90 mmHg or currently on medication for raised 
BP) were considered to count the number of risk factors present. 
 
The prevalence of 3-5 risk factors of the population with age-group and genders is 
demonstrated in Figure (3). 
 
Figure 3. Prevalence of three or more NCD risk factors by age and genders among 25-74 
years old citizens of urban Yangon 
3 or more risk factors of ;current daily smokers, less than 5 serving of fruits and vegetables per day, low physical activity 
(<600 MET-minutes), overweight and obesity (BMI≥25kg/m2), Raised BP (SBP≥140 and/or DBP≥90 mmHg or currently on 
medication for raised BP) 
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3.13 Framingham coronary heart disease risk score 
According to the Framingham risk score, 47.3% males and 28% females were estimated to 
have more than 10% chance of developing CHD during the next 10 years. After age-
adjustment to the WHO world standard population, the adjusted estimates were 33.2% and 
22.2% for males and females, respectively. 
 
3.14  Summary of the prevalence of NCD risk factors among 25-74 years old citizens of 
urban Yangon 
Table (25) presents a summary of the risk factors for NCDs by gender and total, and with 
adjustment to the WHO standard population. We detected high prevalences of 
hypercholesterolemia (52.6%), overweight and obesity (42.6%), hypertension (42%), 
Diabetes Mellitus (13.8%), and the smoking prevalence was high (in males) and 82.9% 
consumed lower level of fruits and vegetables than recommended.  
 
Table 25. Summary of the prevalence of NCDs risk factors among 25-74 years old 
citizens of urban Yangon 
Current smokers- currently smoke daily or less than daily, alcohol drinkers- current drinker within 30 days, Binge drinking- 5 
or more standard drinks for males and 4 or more for females, Low fruits and Vegetables intake < 5 servings of fruits and/or 
vegetables on an average per day, Low physical activity (<600 MET-minutes per week), overweight (BMI 25-29.9kg/m2) and 
obesity (BMI≥30kg/m2), Hypertension (SBP≥140 and/or DBP≥90 mmHg or currently on medication for raised BP), Raised 
FBS ≥ 7.0 mmol/L, Diabetes Mellitus: Raised FBS ≥ 7.0 mmol/L and/or history of Diabetes Mellitus,  Hypercholesterolemia 
≥ 5.17 mmol/L of total cholesterol. 
 Male Female 
Both 
Genders 
Age-standardized 
% 95% CI 
Current smokers 43.4 3.7 23.4 24.3 (21.2-27.4) 
Current drinkers 26.9 1.3 14.0 16.0 (13.4-18.6) 
Binge drinking 11.2 0.3 5.7 7.2 (5.4-9.0) 
Low fruits and Vegetables intake  80.1 84.4 82.3 82.9 (80.2-85.6) 
Low physical activity 15.4 11.6 13.5 12.4 (10.0-14.8) 
Overweight and obesity 35.1 52.8 44 42.6 (39.1-46.1) 
Obesity 7.7 19.0 13.4 12.4 (10.0-14.8) 
Hypertension 48.1 48.3 48.2 42.0 (38.5-45.5) 
Raised fasting blood glucose 12.4 11.3 11.8 8.6 (6.5-10.7) 
Diabetes Mellitus 17.9 18.0 18.0 13.8 (11.2-16.4) 
Hypercholesterolemia 62.7 50.7 56.6 52.6 (48.9-56.3) 
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4. DISCUSSION 
4.1 Summary of the findings  
The present study provides the magnitude of risk factors of non-communicable diseases 
among citizens residing in Urban Yangon Region, the largest urban area of Myanmar. The 
cross-sectional study used WHO STEP survey methodology adapted to the local context 
similar to the method used in a previous study conducted in Yangon in 2003-2004.  
 
The main findings of the present study was the high prevalence of NCDs risk factors, and 
based on Framingham risk scores, 33.2% of males and 22.2% of females had a moderate to 
high risk of developing CHD the next 10 years. Furthermore, we report an alarming high 
prevalence of hypercholesterolemia of 56.6%. In multivariable analysis, we found that high 
age, low education, low income and tobacco use were associated with hypercholesterolemia. 
We also detected that 32 % of the total respondents lived with three or more risk factors of 
NCDs among the study population. 
 
4.2 Methodology  
The present study employed a cross-sectional study design. Cross-sectional studies collect 
simultaneously both the exposure status and outcome status at a single point in time 78.   
 
The present study was intended to estimate the burden of NCD risk factors and to investigate 
the association between hypercholesterolemia and selected risk factors. Since the cross-
sectional design provides the prevalence of diseases and other risk factors, the design meets 
the objective of the present study. The disadvantage of the cross-sectional study limits the 
assessment of the temporal relationship between exposure and outcome. Like other 
epidemiological studies, the present study has certain limitations and weaknesses. Random 
error, selection problem, information problem and confounding are the potential sources of 
the errors in present study. 
 
4.2.1 Validity and reliability  
Validity is defined as the accuracy and appropriateness of the inferences from the analysis of 
the data, whereas reliability is defined as the consistency of measurements in the study 79.  
The threats of the validity could be introduced in all epidemiological studies, therefore, they 
must be minimized in order to have the highest validity of the result of a study. There are two 
types of validity namely, internal validity and external validity.  
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The internal validity refers to the degree to which it can be assumed that changes in the 
independent variable caused changes in the dependent variable 79. The external validity refers 
to generalization of the findings and will be discussed later in this chapter.  
 
There are commonly two types of errors that can affect the epidemiological studies, namely 
random errors and systematic errors 80. These errors are classified based on the selection of 
participants for study or comparison and the measurement of exposures and/or outcomes 80. 
Random error or poor precision is the variability of in the data which occur by chance 81. In 
order to reduce random error in a study, the sample size could be increased. In the present 
study, we have performed sample size calculation and presented figures with 95% confident 
interval.  
 
Systematic error happens systematically through variation of the measurements from the 
accuracy 80. It is also known as bias, and classified broadly into 3 categories : selection bias, 
information bias and confounding 81. 
 
4.2.2 Selection bias 
Occurrence of random and systematic sampling errors depends on the way of selection the 
subjects in a study. Selection bias is a systematic error between those who are included in a 
study and those who are not, or when study and comparison groups are not selected in a 
proper way 80. 
 
Selection bias can be introduced if there is no random selection of participants into the study 
and when those invited to a study refuse to participate in a systematic manner. For example, 
that those with most exposures and/or diseases refuse to participate or are not invited through 
random procedures. In the present study participants were invited to the study through random 
procedures. The response rate was high at 94% in STEP 1 and 2, and 86% in STEP 3. It is 
unlikely that selection problem have affected prevalence estimates in STEP 1 and 2 and 
association measures (OR) significantly. 
 
Prevalence estimates from STEP 3, i.e –estimates, from the blood analyses, could be biased 
due to selection. However it is not possible to indicate which direction estimate are eventually 
distorted. Association measures are more robust to selection problems than prevalence 
estimates 82 83. So it is unlikely, with response rate of 86%, that the estimates of ORs in 
47
analyses of risk factors association with hypercholesterolemia are biased. In the present study 
multistage cluster sampling method was employed in order to achieve a representative sample 
of the study population. 
 
In order not to lose selected invitees, the first meeting with participants was done with the 
assistance of the street-leaders. The cooperation of street leaders may enhance the response 
rate because the leader is a trusted person in the community and he/she supported the study. 
Moreover, the flexible appointments of selected persons who were not at home or works 
reduced drop-out. During the data collection, none of the non-responder with other volunteers 
were replaced. In fact, due to logistic and social context, three volunteers, who were keen to 
be a part of the health survey, took part in the study but their data were not entered in the data 
files. The three volunteers received results from the examination, only. 
  
4.2.3 Information bias 
Information bias is a systematic error in measurement or by misclassifying the subject for 
exposure and/or outcome variables in a study 80. The misclassification can be differential or 
non-differential 80.  According to Kenneth J. Rothman 81: 
 
“For exposure misclassification, the misclassification is non-differential if it is unrelated to 
the occurrence or presence of disease; if the misclassification of exposure is different for 
those with and without disease, it is differential. Similarly, misclassification of disease 
(outcome) is non-differential if it is unrelated to the exposure; otherwise. it is differential.” 81 
 
In a prevalence study, the most common types of information bias include interviewer bias, 
questionnaire bias and recall bias. Interviewer bias comes when systematic differences occur 
while asking, recording, or interpreting of information from the participants.  
The present study might have recall bias in the self-reported measures for the behavioral risk 
factors. Some participants, for instance, might under-report on alcohol consumption and 
tobacco use leading to lowering of prevalence estimates84,85. Physiological changes during 
pregnancy can alter the result of physical measurement and biomedical results 86. We, 
therefore, excluded 3 pregnant female participants from the data analysis in this study.  
 
In order to control potential information bias, a proper training was given to the fieldworkers. 
Furthermore, all the questionnaires were adapted to WHO STEP methodology and the 
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instruments were standardized before the data collection. The methods have been applied in 
Myanmar setting and languages in two previous studies. The questionnaire have been slightly 
modified and tested. However, the validity of the Myanmar version has not been validated, 
and is, thus, a weakness of the study. 
 
 Anthropometric measurements and the simple clinical examination were performed 
following the WHO standards procedures. Operational definitions were well-defined. A pilot 
study was conducted to standardize questionnaires and physical measurements. As a 
limitation, blood drawing and investigation were not included in the pre-test. Another 
limitation was that the validation of the blood results from National Health Laboratory was 
not evaluated in another laboratory. However, the National Health Laboratory, Yangon is the 
only main reference laboratory of Myanmar known as a WHO reference Laboratory, therefore 
quality control of the laboratory results were highly certified with minimum systematic error.  
 
4.2.4 Confounding  
A confounding factor is a factor that is associated with both exposure and outcome 81. 
Thus, confounding is mainly related to the present analyses of the association between risk 
factors and hypercholesterolemia. We used a multivariate method (logistic regression 
analysis), controlling for confounding. There might be unmeasured confounders that were not 
included the study, (for instance, taking cholesterol lowering drugs, social pressure, seasonal 
variation). Most often such unmeasured confounders may change the estimates towards the 
null-value. 
 
Regarding to the prevalence estimates, they were most often presented by age groups and 
genders to remove the effect of age and genders. Moreover, the prevalence of selected 
important risk factors was presented with age-adjustment to the WHO world standard 
population.  
 
Three pregnant participants were excluded from the data analysis to avoid confounding since 
the physiological and metabolism changes can affect the results on physical examination and 
laboratory examination. We decided that 3 pregnant women were too little to make an 
additional stratified group.   
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4.3 Discussion of the main findings 
4.3.1 Tobacco use  
The crude prevalence of current smoking was 23% which is quite similar to urban Cambodian 
(24.8%) 87, and also quite similar to a previous study from urban Yangon study (25%) in 
200323, and also similar to the 2009 national figure of Myanmar(22%) 24. The current 
smoking rate was higher than that in the urban Jaipur of India (14.5%) 88, and it is lower than 
in the urban areas of Thailand (36%) 89 and Nepal (36%) 90. Similar to the regional and 
national figures 29, current smoking prevalence in males outnumbered females and was more 
than 10 times higher than in females. The overall prevalence of smokeless tobacco was 28% 
(40% for males and 15.6% for females), which was slightly lower than that in the 2009 
nationwide figure 30% (51% for males and 16 % for females) 24. 
 
The results indicate that tobacco consumption is a public health problem in Myanmar. The 
implementation of law on control of smoking and consumption of tobacco products is still 
weak in Myanmar. As a result, tobacco advertising and promotion, easy accessibility and 
cheap price of tobacco product may have enhanced Myanmar’s tobacco use. Additionally, 
smokeless tobacco use, particularly betel chewing and tobacco, is highly common in 
Myanmar and has become a socio-cultural entertaining habit 31. As a matter of fact, people 
had the misconception that smokeless tobacco is less harmful than smoking 31,91.  
 
 
4.3.2 Alcohol consumption  
Similar to South-East Asian countries 13, alcohol consumption was higher among males than 
among females. The prevalence of current drinker (14%) was compared with national figures 
from 2009 (13%) 24. Among males, the current drinking rate (27%) was similar with urban 
Kerala (27%) 92, and much lower than urban Kathmandu ( 58%) 90. About 1 % of females 
were current drinkers in the present study, which was lower than from urban Kathmandu 
(24.9%) 90; national figures of Bhutan (26%), and Nepal (17%) 13.  
 
Some studies have reported that light to moderate amount of alcohol consumption enhances 
the cardio-protective effect 35, by increasing serum HDL level and decreasing serum LDL 36. 
It does not mean that the harmful use of alcohol should be overlooked as it has several serious 
side effects as injuries, violence and drank-driving 34. Binge drinking was lower than reported 
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in urban Cambodian (45.1% in males and 3.4% in females) 87, and could possibly be under-
reported  as it is socially represents poor behaviors.  
 
4.3.3 Fruits and vegetables consumption 
82% of the population did not fulfil the WHO recommends of eating more than five servings 
of fruits and vegetables (400g) on average in a day, which is believe to minimize the burden 
of NCDs 38. A higher prevalence of adequate fruits and vegetables consumption was observed 
among males than females which is in accordance with other South-East-Asian Countries 13. 
 
The prevalence of adequate fruit and vegetables consumption was found to be considerably 
lower than in the urban Kerala (62%) 92 and national data of Bhutan (33%) and Nepal 
(38%)13. In contrary, the present study showed a higher percentage of adequate fruits and 
vegetables consumption than previous studies from Myanmar in 2003-4 (92%) 23 and 2009 
(90%) 24, and higher than urban Bangladesh(4%) 93, the national data of Indonesia (6%) and 
Maldives (3%) 13.  
 
Unhealthy dietary intake was not a surprise in the South-East-Asian Region due to the low 
socioeconomic condition and poor awareness in the majority of the population. Nevertheless, 
an agricultural country like Myanmar could increase the consumption of fruits and vegetables 
due to the good availability in the country, contributing to a reduction in NCDs.  
 
4.3.4 Physical inactivity  
The prevalence of low physical activity (14%) was low as compared with urban Jaipur 
(70%)88 and Kathmandu (32%) 90. However, compared to the previous study from urban 
Yangon in 2003, it is an increase in the prevalence of low physical activity from 9% to 14% 
23. This could be due to the general trend of urbanization, a shift towards a more sedentary 
westernized lifestyle. More males than females were physically inactive in the present study, 
similar with Indonesia national data which reported 32% in males and 29% in females 13. In 
contract, most of South-East-Asian countries 13, urban Bangladesh 93 and in the national study 
in Myanmar 24, more female than males were physically inactive.   
 
The study population possessed high level of physical activities, probably; this may be due to 
the nature of their work and level of economic development in Myanmar. Unlike developed 
countries, in the present study physical activity generally occurred at work place, house 
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chores and transport in the present study. Probably due to poor transportation system in 
Yangon, city dwellers attain physical activity from the walking on a regular basis. Few 
attained the leisure related physical activity.  
 
4.3.5 Body mass index (Overweight and Obesity) 
A high prevalence of overweigh/obesity was reported in the present study. This is in 
accordance with reports from urban Jaipur (48 %) 88 and urban Palestine(41%) 94. Similar to 
other South-East Asian countries 13, urban Bangladesh 93 and national data of Cambodia 87, a 
higher proportion of females were overweight compared to males. Nineteen percentage of 
females were obese (BMI ≥30 Kg/m2), which was 2 times higher than 2009 national 
prevalence (8%) 24, and much higher than the report in  the urban Yangon study in 2003 (less 
than 1%) 23. The reason of surge trend of obesity was probably due to changes in dietary 
pattern and lifestyles. 
    
Already in 2005 it was reported that in most developing countries the prevalence of 
overweight women is higher than the prevalence of underweight women 95, which is in 
accordance with present study. Based the suggested WHO BMI cut-off for the Asian 
population, the prevalence of overweight and obesity (61%) was higher than that of the 
standard cut-off. People in Myanmar believe that fat body could be an indicator or sign of the 
good health and prosperity rather than having a thin and emaciated shape. This could have led 
to a misunderstanding that overweight is not a risk of chronic diseases. 
    
4.3.6 Blood pressure   
A high prevalence of hypertension was observed in the present study. The age-standardized 
prevalence rate was 42%, which was identical with the national figure of Myanmar from 
200924, but higher than urban Yangon from 2003 (30.5%) 23 and similar with Indonesia 
(41%)96. The findings were also quite close to age-standardized WHO estimates for the 
South-East-Asian region (37%) and Global(38%) 96. The present figure was as high as 
compared with urban population of Jaipur (34%) 88 and Kathmandu(28%) 90. A recent study 
from four townships of Myanmar reported in 2013 a hypertension prevalence of (57%) 56. The 
finding of increasing trend of hypertension as compared with data for 2003 is in line with the 
findings in the other countries of South-East-Asia region 96.  
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The main reason for such a surge could probably be explained with the changes in dietary 
pattern and lifestyle. Studies reported that salt-intake in South-East Asian countries was very 
high97. Furthermore, the increase in use of mono-sodium glutamate (MSG) could be major 
contributor of the burden of hypertension. MSG and salt intake are highly associated with 
high blood pressure98-100.  
The mean systolic and diastolic blood pressure (132/82 mmHg) in the present study is far 
from the optimal blood pressure (115/75 mmHg) 101. An increase in blood pressure by 20/10 
mmHg may double the risk of CVDs 102. Thus, the present population of adults in urban 
Yangon is close to having double risk of CVDs. 
 
This study shows that hypertension is an important public health problem of urban Yangon.  
Although awareness among the hypertensives was 68%, the coverage of the treatment and 
control were poor. Better coverage of controlled hypertension were found in neighboring 
countries 96 such as in Thailand (43%) and in Bangladesh (42%) than the present study(28%). 
Although the awareness and control rate  have increased from 53% to 62% and 11% to 27%, 
respectively, as compared to the previous study in Yangon in 2003 45, the improvement is not 
sufficient. Hence, further prevention and control activities are needed. Further study of risk 
factors of hypertension should be conducted for identifying the preventive strategies of 
hypertension in Myanmar.  
 
4.3.7 Blood glucose 
The present study reported a high diabetes prevalence (18%) with no gender difference. The 
age-standardized prevalence was 13.8%, which is higher than reported in the previous study 
of Yangon in 2003 23. Similarly,  earlier studies in Asia showed an increasing trend in 
diabetes prevalence, particularly in urban areas 103, a 10-fold  increase from 1.2% to 12% 
from 1971-2000 was reported in urban India 104,105, seven-fold increase from 1990-1999 in 
urban Nepal 106,107, and about double-fold increase from 2001-2008 in urban areas of 
mainland China 103,108,109. Urbanization and rapid changes in lifestyle in Asia could be 
predisposing factors for this increasing trend. It has also been suggested that Asian people 
have favorable ethnic and genetic conditions for poorer threshold for the environmental risk 
factors and increasing the risk of diabetes 103.  
 
The findings of the present study indicated a high burden and poor control of diabetes in 
urban areas of Yangon. A recent study reported that the knowledge, attitude and practice of 
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Myanmar people with diabetes is still poor, and that people with diabetes have ineffective 
diabetes care because of various socio-cultural beliefs leading to denying the seriousness of 
the disease 110. 
 
4.3.8 Blood lipid profiles 
In line with an increasing trend of increasing cholesterol levels in South-East Asian countries 
52, the total cholesterol in the present study was higher than in the Yangon study from 2003 23. 
The level was also higher than the worldwide age-standardized mean cholesterol (4.64 
mmol/L in males and 4.76 mmol/L in females) 52.  
 
The present study reports high prevalences of hypercholesterolemia and low HDL. The 
prevalence of raised total cholesterol level in the present study was similar to the urban Kerala 
(61%) 92 and national figures of Thailand and Maldives in 2008(above 50 %)13. However, it 
was higher than the previous study from Yangon in 2003 23,and compared with an urban 
Cambodian study in 2010 87. A very high prevalence of low HDL (77%) was found among 
females of our study, but lower than found among females in the urban population of eastern 
India (85%)111 and lower than that of Jaipur (44%) 88.  
 
The study reports an association between hypercholesterolemia and higher age, tobacco use, 
low education as compared with higher education, and low income as compared with high 
income of >5 USD per day. This is in accordance with some studies which have shown an 
association between hypercholesterolemia and tobacco use 112,113 and age 114,115.  
 
4.3.9 Combined risk factors and Framingham coronary heart disease risk score 
It was observed that 3.3 % of the study population had none of the mentioned NCD risk 
factors, slightly lower than Myanmar national figures (4.3%) 24 and lower than urban 
Cambodian in 2010 (10.3%) 87. We detected only slightly higher prevalence of 3 or more 
combined risk factors in males (33%) than in females (30%). This is similar to urban 
Katmandu (41%,31%) 90, Cambodia (14%,7%) 87, and national figures from Myanmar in 
2009 24. The prevalence of 10 years risk of CHD was higher among males (47%) than females 
(28%). A recent study of four townships in Myanmar showed almost no difference between 
genders (50% in males and 48% in female)56. The high prevalence of total cholesterol and 
smoking among males may have contributed to the present high 10 years risk of CHDs.     
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4.4 External validity (Generalization)  
External Validity refers to the degree to which it can be generalized from the results and 
inferences reached with a sample to the population79.  High internal validity is a prerequisite 
for the external validity.  
 
Regarding the prevalence estimates, the data were collected from the 6 urban townships of the 
Yangon region; therefore it is most possible to generalize as to the whole urban Yangon 
region. The difference of behavior and lifestyles between the rural and urban population is 
large. However, the present prevalence estimates represent the urban population of Yangon 
region and might be applicable for other large urban areas of Myanmar. The present data 
represents findings from the most urbanized area of Myanmar and could be seen as a 
comparison group for future studies.  
 
The factors found to be associated with hypercholesterolemia are in accordance with previous 
studies; and association measures are relatively robust even if there had been some degree of 
selection bias (which is most likely not present in this study); and we have adjusted for the 
potential confounders, but, there might be some unmeasured confounders such taking lipid 
lowering drugs. Thus we believe that the association measures from the present study can be 
generalized to a wider population or to a general population. 
 
4.5 Conclusion and the recommendation 
The present study shows that the prevalences of NCD risk factors in the urban population of 
the Yangon region are generally high. Compared with a previous study from the same area 
conducted in 2003, the prevalences of the risk factors seem to be on rise. There were gender 
differences with higher prevalence in males than females for smoking, current alcohol 
drinking, and hypercholesterolemia, and lower prevalence for males regarding overweight and 
obesity. 
Almost all adult urban citizens of Yangon have more than one the risk factors present, and 
one third has 3-5 risk factors present. No gender differences were found. Based on the 
Framingham risk estimates, more that one-fourth of the population have moderate to high risk 
of developing CHD within the next 10 years. Slightly more males than females belong to this 
risk group. 
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The present study indicates that there is social inequity in the occurrence of 
hypercholesterolemia, with higher prevalences among those with low income and education.  
Taken together, the findings of the present study indicate an increasing trend in NCD risk 
factors, that will result in an increase in NCDs. This will put an enormous pressure on the 
Myanmar health system, and prevention strategies should be given high priority.  
 
We recommend that strategies to be put forward should target the whole population, and 
regarding smoking it is important with strategies that prevent women from starting smoking. 
Similar to most low income countries, there is a need to increase the level of education and 
income of the population, and provide health information to increase the awareness of 
diseases. 
 
Detailed analysis of the present study should be published nationally to inform policy makers 
and NGOs and internationally to inform donors and international NGOs. Coordinated actions 
are needed to reduce NCDs and their risk factors. The data should be presented to the 
Ministry of Health for further utilization. The government should be responsible for the health 
of its population; to ensure that domestic financing for health is sufficient, efficient, equitable 
and sustainable. The Myanmar government should continue to increase the expenditure on 
health, perhaps increasing the speed. 
 
An agricultural country like Myanmar should consider how to increase consumption of fruits 
and vegetables. Since the result showed that prevalence of some NCD risk factors are gender-
related, the socio-cultural issue on preventive measures should be taken into consideration. 
Due to the high prevalence of hypercholesterolemia and hypertension, further studies of their 
associated factors should be conducted for the purpose of preventive strategies. Preventive 
programs aiming at reducing NCD risk factors have been conducted and evaluated in both 
low- and high income counties settings. Such programs could be adjusted to the local culture 
of Myanmar and implemented in selected areas, and the effect should be evaluated. 
 
Programs for the raising the awareness regarding side effect of smokeless tobacco 
consumption, particularly betel quid chewing should be developed. This survey estimated the 
prevalence of NCD risk factors in urban areas of Yangon. A rural study should be conducted 
for comparison, and further studies should be done at later stage probably next 5 and 10 years 
to assess the trends of risk factors among the population.   
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Appendix 1  
Selected Townships and wards of the present study 
 
(1) Mingalar-Taung-Nyunt Township (5 wards from total 20 wards) 
i. Kantawkalay –West 
ii. Taung-Nyunt-Ya-Htar 
iii. Taung lone Pyan 
iv. San Pya Pha Sa Pa Hla 
v. Thar Yar Gone 
 
(2) Bahan ( 5 wards from total 22 wards) 
i. Sayar San North-East 
ii. Bo Sein Hman 
iii. Kyeik Ka San 
iv. Sar sa Na yeik thar 
v. Ye Tar Shay  
 
(3) KamaYut (5 wards from total 10 wards) 
i. Ward 3 
ii. Ward 5 
iii. Ward 7 
iv. Ward 8 
v. Ward 1 
 
(4) Innsein( 5 wards from total 21 wards) 
i. Kan-Nar-Central 
ii. Pauk-Taw 
iii. Myo Thit (Ka+Kha) 
iv. Kyoe Kone-east 
v. Ywar ma- west 
 
(5) South-Dagon (5 wards from total 26 wards) 
i. Ward 20 
ii. Ward 21 
iii. Ward 54 
iv. Ward 70 
v. Ward 140 
 
(6) South-Okkalapa (5 wards from total 13 wards) 
i. Ward 4 
ii. Ward 9 
iii. Ward 7 
iv. Ward 10 
v. Ward 11 
 
 Ward is a part of townships.  
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Appendix 2  Invitation to participate in the health survey 
Dear Mr/Ms ………………,       Date:___________ 
We would like to invite you to participate in the health survey, which will be held in (address 
of the Place), at date_____(month) (day) : (hour) ____. 
The general objective of this survey is to determine the potential risk factors that can affect 
the health especially chronic diseases (e.g cardiovascular diseases, hypertension, diabetes, 
etc). We would like to invite 800 men and women aged 25-74 years in the urban area of 
Yangon. Research period will be from September 2013 to November 2013.  The researcher 
from the Ministry of Health, Myanmar will lead and carry out the data collection accordingly. 
The ethical consideration of this survey had been cleared by Norwegian Regional Committees 
for Medical and Health Research Ethics (REK) and the Ethical Review Committee of 
Department of Health (Myanmar). 
The components of the survey include interviewing about health, measurements of body 
weight, height, waist and hip circumference, blood pressure and taking out blood sample for 
testing blood glucose and lipids.  
We ensure that all of participants have right to withdraw from the study any time as they 
wish. After completion of the study, the research team will share the examination results only 
with participants who want to know their results. The information you provide is totally 
confidential and will not be disclosed to anyone.  It will only be used for research purposes. 
All information will be handled confidentially.  
In order to obtain valid health information, please be informed you the following guidelines 
for blood investigation by the time you come the investigating site at the scheduled date: 
1. Abstaining from all kinds of food and drink with the exception of plain water 10 hours 
before coming to the research site. 
2. If you are on any kind of long term medications, please bring them with your medical 
history book to research site to show to the research team. 
Thanking you in anticipation of your kind cooperation. 
With regards, 
Dr. Aung Soe Htet 
Principal Investigator 
Ministry of Health 
09-31240299 
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┘ Appendix 3  
NCD RISK FACTORS SURVEY IN URBAN AREA OF YANGON, MYANMAR 
Survey Information 
Location and Date Response Code 
1 
Cluster/Centre/Village ID 
 
 
└─┴─┘ 
I1 
2 
Name of Township 
 
 
 
I2 
3 
Interviewer ID 
 
 
└─┴─┘ 
I3 
4 
Date of completion of the instrument 
 
 
                           └─┴─┘ └─┴─┘ └─┴─┴─┴─┘ 
                                dd             mm             year 
I4 
 
 
 
 
 
Participant Id Number  └─┴─┘  └─┴─┘└─┴─┘   
Consent, Interview Language and Name Response Code 
5 
Consent has been read and obtained 
 
Yes 1 
I5 
No 2       If NO, END 
6 
Interview Language (Myanmar) 
 
Myanmar 1 
I6 
[Add others] 2 
[Add others] 3 
[Add others] 4 
7 
Time of interview  
(24 hour clock) 
 
 
 
└─┴─┘: └─┴─┘ 
             hrs                mins 
I7 
8 
Participant Name 
 
  
I8 
Additional Information that may be helpful 
9 
Contact phone number where possible  
 
 I1 
 
Record and file identification information (I5 to I10) separately from the completed questionnaire. 
  
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Step 1   Demographic Information 
 
CORE: Demographic Information 
Question Response Code 
10 Sex (Record Male / Female as observed) 
Male 1 
C1 
Female 2 
11 
What is your date of birth?  
Don't Know 77 77 7777    
 
└─┴─┘ └─┴─┘ └─┴─┴─┴─┘ If known, Go to C4 
    dd              mm                year 
C2 
12 How old are you?  Years 
 └─┴─┘ C3 
13 
In total, how many years have you spent at school or 
in full-time study (excluding pre-school)?  
Years 
  └─┴─┘ C4 
 
EXPANDED: Demographic Information 
14 
What is the highest level of education you have 
completed? 
 [INSERT COUNTRY-SPECIFIC CATEGORIES] 
 
No formal schooling 1 
C5 
Less than primary  school 2 
Primary school completed 3 
Secondary school completed 4 
High school completed 5 
College/University completed 6 
Post graduate degree 7 
Refused 88 
15 
What is your [insert relevant ethnic group / racial group / 
cultural subgroup / others] background? 
 
[Burma] 1 
C6 [Kachin] 2 
[Kaya] 3 
Refused 88 
16 
What is your marital status? 
 
 
Never married 
1 
C7 
Currently married 2 
Separated 3 
Divorced 4 
Widowed 5 
Refused 88 
17 
Which of the following best describes your main work 
Government employee 1 C8 
Non-government employee 2 
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status over the past 12 months? 
[INSERT  COUNTRY-SPECIFIC CATEGORIES] 
(USE SHOWCARD) 
 
 
Self-employed 3 
Non-paid 4 
Student 5 
Homemaker 6 
Retired 7 
Unemployed (able to work) 8 
Unemployed (unable to work) 9 
Refused 88 
18 
How many people older than 18 years, including 
yourself, live in your household? 
Number of people 
└─┴─┘ 
C9 
19 Taking the past year, can you tell me what the 
average earnings of the household have been? 
(RECORD ONLY ONE, NOT ALL 3) 
 
Per week └─┴─┴─┴─┴─┴─┴─┘     C10a 
OR per month └─┴─┴─┴─┴─┴─┴─┘     C10b 
OR per year └─┴─┴─┴─┴─┴─┴─┘     C10c 
Refused 88 C10d 
 
Step 1    Behavioural Measurements 
CORE:  Tobacco Use 
Now I am going to ask you some questions about various health behaviours. This includes things like smoking, drinking alcohol, eating fruits 
and vegetables and physical activity. Let's start with tobacco. 
Question Response Code 
20 
Do you currently smoke any tobacco products, such 
as cigarettes, cigars or pipes? (USE SHOWCARD)   
 
Yes 1 
T1 
No 2      If No,  go to T6 
21 
Do you currently smoke tobacco products daily?  
 
Yes 1 
T2 
No 2      If No,  go to T6     
22 How old were you when you first started smoking 
daily? 
 
Age (years) 
└─┴─┘ If known, go to T5a 
T3 
Don’t know  77 
23 Do you remember how long ago it was?  
(RECORD ONLY 1, NOT ALL 3) 
 
In Years └─┴─┘ If known, go to T5a T4a 
OR       in Months └─┴─┘ If known, go to T5a T4b 
OR       in Weeks └─┴─┘ T4c 
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Don’t know  77 
 
24 On average, how many of the following do you smoke 
each day?  
 
(RECORD FOR EACH TYPE) 
 
Don’t know  77 
 
 
Manufactured cigarettes └─┴─┘ T5a 
Hand-rolled cigarettes └─┴─┘ T5b 
Pipes full of tobacco └─┴─┘ T5c 
Cigars, cheroots, cigarillos └─┴─┘ T5d 
Other 
 If Other, go to T5other,               
└─┴─┘ else go to T9 
T5e 
Other (please specify): 
└─┴─┴─┴─┴─┴─┴─┘  
                    Go to T9 
T5other 
 
EXPANDED:  Tobacco Use 
Question Response Code 
25 In the past, did you ever smoke daily? 
 
Yes 1 
T6 
No 2    If No,  go to T9 
26 How old were you when you stopped smoking daily? 
 
Age (years) 
└─┴─┘ If Known, go to T9 
T7 
Don’t Know  77 
27 Do you remember how long ago it was? 
(RECORD ONLY 1, NOT ALL 3) 
 
Don’t know 77 
In Years └─┴─┘ If Known, go to T9 
T8a 
OR       in Months └─┴─┘ If Known, go to T9 
T8b 
OR      in Weeks └─┴─┘ 
T8c 
28 Do you currently use any smokeless tobacco such 
as [snuff, chewing tobacco, betel]? 
(USE SHOWCARD) 
Yes 1 
T9 No 2       If No, go to T12 
29 Do you currently use smokeless tobacco products 
daily?  
 
Yes 1 
T10 
No 2      If No, go to T12 
30 On average, how many times a day do you use …. 
 
Snuff, by mouth └─┴─┘ T11a 
Snuff, by nose └─┴─┘ T11b 
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(RECORD FOR EACH TYPE, USE SHOWCARD) 
 
Don't Know 77 
 
Chewing tobacco └─┴─┘ T11c 
Betel, quid └─┴─┘ T11d 
Other 
 If Other, go to T11 other, 
└─┴─┘ else go to T13 
T11e 
Other (specify) └─┴─┴─┴─┴─┘  Go to T13 T11other 
31 In the past, did you ever use smokeless tobacco such 
as [snuff, chewing tobacco, or betel] daily? 
 
Yes 1  
T12 
No 2  
     Don't know or don't 
work in a closed area 77  
 
CORE:  Alcohol Consumption 
The next questions ask about the consumption of alcohol. 
Question Response Code 
32 
Have you ever consumed an alcoholic drink such as 
beer, wine, spirits, fermented cider or [add other local 
examples]? 
(USE SHOWCARD OR SHOW EXAMPLES) 
Yes 1 
A1a 
No 2    If No, go to D1 
33 
Have you consumed an alcoholic drink within the past 
12 months? 
Yes 1 
A1b 
No 2    If No, go to D1 
34 
During the past 12 months, how frequently have you 
had at least one alcoholic drink?   
 
(READ RESPONSES, USE SHOWCARD)  
 
Daily 1 
A2 
5-6 days per week 2 
1-4 days per week 3 
1-3 days per month 4 
Less than once a month 5 
35 Have you consumed an alcoholic drink within the past 
30 days? 
Yes 1 A3 
No 2     If No, go to D1 
36 
During the past 30 days, on how many occasions did 
you have at least one alcoholic drink? 
Number  
Don't know 77 └─┴─┘ 
A4 
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37 
During the past 30 days, when you drank alcohol, on 
average, how many standard alcoholic drinks did 
you have during one drinking occasion? 
(USE SHOWCARD) 
Number  
Don't know 77 
└─┴─┘ 
A5 
38 
During the past 30 days, what was the largest number 
of standard alcoholic drinks you had on a single 
occasion, counting all types of alcoholic drinks 
together? 
Largest number 
Don't Know 77 
└─┴─┘ 
A6 
39 
During the past 30 days, how many times did you have  
for men: five or more  
for women: four or more 
standard alcoholic drinks in a single drinking occasion? 
Number of times 
Don't Know 77 
└─┴─┘ 
A7 
 
EXPANDED:  Alcohol Consumption 
40 
During the past 30 days, when you consumed an 
alcoholic drink, how often was it with meals? Please do 
not count snacks. 
Usually with meals 1 
A8 Sometimes with meals 2 
Rarely with meals 3 
Never with meals 4 
41 
During each of the past 7 days, how many standard 
alcoholic drinks did you have each day?  
 
(USE SHOWCARD) 
 
 
Don't Know 77 
Monday 
└─┴─┘ 
A9a 
Tuesday └─┴─┘ 
A9b 
Wednesday └─┴─┘ 
A9c 
Thursday 
└─┴─┘ 
A9d 
Friday 
└─┴─┘ 
A9e 
Saturday └─┴─┘ 
A9f 
Sunday └─┴─┘ 
A9g 
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CORE: Diet 
The next questions ask about the fruits and vegetables that you usually eat. I have a nutrition card here that shows you some examples of 
local fruits and vegetables. Each picture represents the size of a serving. As you answer these questions please think of a typical week in the 
last year. 
Question Response Code 
42 In a typical week, on how many days do you eat fruit? 
(USE SHOWCARD) 
Number of days 
 
Don't Know 77 
└─┴─┘     If Zero days, go to  D3 D1 
43 How many servings of fruit do you eat on one of those 
days?  (USE SHOWCARD) 
Number of servings 
Don't Know 77 └─┴─┘ D2 
44 In a typical week, on how many days do you                 
eat vegetables? (USE SHOWCARD) 
Number of days 
 
Don't Know 77 
└─┴─┘     If Zero days, go to  D5 
D3 
45 How many servings of vegetables do you eat on one of 
those days? (USE SHOWCARD) 
Number of servings  
Don’t know 77 └─┴─┘ 
D4 
 
EXPANDED: Diet 
46 What type of oil or fat is most often used for meal 
preparation in your household?  
 
(USE SHOWCARD, 
SELECT ONLY ONE) 
 
Vegetable oil 1 
        D5 
Lard or suet 2 
Butter or ghee 3 
Margarine 4 
Other 5      If Other, go to D5other 
None in particular 6 
None used 7 
Don’t know 77 
Other 
└─┴─┴─┴─┴─┴─┴─┘ D5other 
47 
On average, how many meals per week do you 
eat that were not prepared at a home? By meal, I 
mean breakfast, lunch and dinner. 
Number 
Don’t know 77 └─┴─┘ 
D6 
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 CORE:  Physical Activity 
Next I am going to ask you about the time you spend doing different types of physical activity in a typical week. Please answer these questions 
even if you do not consider yourself to be a physically active person.  
Think first about the time you spend doing work.  Think of work as the things that you have to do such as paid or unpaid work, study/training, 
household chores, harvesting food/crops, fishing or hunting for food, seeking employment. [Insert other examples if needed].  In answering the 
following questions 'vigorous-intensity activities' are activities that require hard physical effort and cause large increases in breathing or heart 
rate, 'moderate-intensity activities' are activities that require moderate physical effort and cause small increases in breathing or heart rate. 
Question Response Code 
Work 
48 
Does your work involve vigorous-intensity activity that 
causes large increases in breathing or heart rate like 
[carrying or lifting heavy loads, digging or construction 
work]  for at least 10 minutes continuously?  
[INSERT EXAMPLES]  (USE SHOWCARD) 
Yes 1 
P1 
No 2     If No, go to P 4 
49 In a typical week, on how many days do you do 
vigorous-intensity activities as part of your work? 
Number of days └─┘ P2 
50 
How much time do you spend doing vigorous-intensity 
activities at work on a typical day? Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                mins 
P3 
(a-b) 
51 
Does your work involve moderate-intensity activity, that 
causes small increases in breathing or heart rate such 
as brisk walking [or carrying light loads]  for at least 10 
minutes continuously?   
 [INSERT EXAMPLES]   (USE SHOWCARD) 
Yes 1 
P4 
No 2      If No, go to P 7 
52 In a typical week, on how many days do you do 
moderate-intensity activities as part of your work?  
Number of days └─┘ P5 
53 
How much time do you spend doing moderate-intensity 
activities at work on a typical day? Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                mins 
P6 
(a-b) 
Travel to and from places 
The next questions exclude the physical activities at work that you have already mentioned. 
Now I would like to ask you about the usual way you travel to and from places.  For example to work, for shopping, to market, to place of 
worship. [Insert other examples if needed] 
54 
Do you walk or use a bicycle (pedal cycle) for at least 
10 minutes continuously to get to and from places? 
Yes 1 
P7 
No 2      If No, go to P 10 
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55 
In a typical week, on how many days do you walk or 
bicycle for at least 10 minutes continuously to get to 
and from places? 
Number of days └─┘ 
P8 
56 
How much time do you spend walking or bicycling for 
travel on a typical day?  
Hours : minutes 
└─┴─┘: └─┴─┘ 
     hrs               mins 
P9 
(a-b) 
Recreational activities 
The next questions exclude the work and transport activities that you have already mentioned. 
Now I would like to ask you about sports, fitness and recreational activities (leisure), [Insert relevant terms]. 
57 
Do you do any vigorous-intensity sports, fitness or 
recreational (leisure) activities that cause large 
increases in breathing or heart rate like [running or 
football]  for at least 10 minutes continuously?  
[INSERT EXAMPLES]   (USE SHOWCARD) 
Yes   1 
P10 
No 2      If No, go  to P 13 
58 
In a typical week, on how many days do you do 
vigorous-intensity sports, fitness or recreational 
(leisure) activities? 
Number of days 
└─┘ 
P11 
59 
How much time do you spend doing  vigorous-intensity 
sports, fitness or recreational activities on a typical day? Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                mins 
P12 
(a-b) 
60 
Do you do any moderate-intensity sports, fitness or 
recreational (leisure) activities that cause a small 
increase in breathing or heart rate such as brisk 
walking, [cycling, swimming, volleyball] for at least 10 
minutes continuously? 
 [INSERT EXAMPLES]   (USE SHOWCARD) 
Yes   1 
P13 
No 2      If No, go to P16 
61 
In a typical week, on how many days do you do 
moderate-intensity sports, fitness or recreational 
(leisure) activities?  
Number of days 
 
└─┘ 
P14 
62 
How much time do you spend doing moderate-intensity 
sports, fitness or recreational (leisure) activities on a 
typical day? 
Hours : minutes 
 
└─┴─┘: └─┴─┘ 
    hrs                mins 
P15 
(a-b) 
 
EXPANDED: Physical Activity 
Sedentary behavior 
The following question is about sitting or reclining at work, at home, getting to and from places, or with friends including time spent sitting at a 
desk, sitting with friends, traveling in car, bus, train, reading, playing cards or watching television, but do not include t ime spent sleeping. 
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[INSERT EXAMPLES]   (USE SHOWCARD) 
63 
How much time do you usually spend sitting or reclining 
on a typical day? 
 
Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                min s 
P16  
(a-b) 
 
CORE: History of  Raised Blood Pressure 
Question Response Code 
64 
Have you ever had your blood pressure measured by a 
doctor or other health worker? 
Circle the appropriate response. 
 
Yes 1 
H1 
No 2       If No, go to H6 
65 
Have you ever been told by a doctor or other health 
worker that you have raised blood pressure or 
hypertension? 
Circle the appropriate response. 
 
 
Yes 1 
H2a 
No 2       If No, go to H6 
66 
Have you been told in the past 12 months? 
 
Yes 1 
H2b 
No 2  
 
EXPANDED: History of  Raised Blood Pressure 
67 
Are you currently receiving any of the following treatments/advice for high blood pressure prescribed by a doctor or other health worker? 
Drugs (medication) that you have taken in the past two 
weeks 
Yes 1 
H3a 
No 2 
Advice to reduce salt intake 
Yes 1 
H3b 
No 2 
Advice or treatment to lose weight 
Yes 1 
H3c 
No 2 
Advice or treatment to stop smoking 
Yes 1 
H3d 
No 2 
Advice to start or do more exercise 
Yes 1 
H3e 
No 2 
68 
Have you ever seen a traditional healer for raised blood 
pressure or hypertension? 
Yes 1 
H4 
No 2 
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69 
Are you currently taking any herbal or traditional 
remedy for your raised blood pressure? 
Yes 1 
H5 
No 2 
 
CORE: History of  Diabetes 
Question Response Code 
70 
Have you ever had your blood sugar measured by a 
doctor or other health worker? 
Yes 1 
H6 
No 2       If No, go to M1 
71 
Have you ever been told by a doctor or other health 
worker that you have raised blood sugar or diabetes? 
Circle the appropriate response. 
 
Yes 1 
H7a 
No 2       If No, go to M1 
 
EXPANDED: History of Diabetes 
72 Drugs (medication) that you have taken in the past two 
weeks 
Yes 1 H7b 
No 2 
73 
Are you currently receiving any of the following treatments/advice for diabetes prescribed by a doctor or other health worker? 
Insulin 
Yes 1 
H8a 
No 2 
Special prescribed diet 
Yes 1 
H8b 
No 2 
Advice or treatment to lose weight 
Yes 1 
H8c 
No 2 
Advice or treatment to stop smoking 
Yes 1 
H8d 
No 2 
Advice to start or do more exercise 
Yes 1 
H8e 
No 2 
74 
During the past 12 months have you ever seen a 
traditional healer for diabetes or raised blood sugar? 
Yes 1 
H9 
No 2 
75 
Are you currently taking any herbal or traditional 
remedy for your diabetes? 
Yes 1 
H10 
No 2 
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Step 2    Physical Measurements 
 
CORE:  Height and Weight 
Question Response Code 
76  
 
 
M1 
77 Device IDs for height and weight 
Height 
└─┴─┘ M2a 
Weight 
└─┴─┘ M2b 
78 
Height 
 
in Centimetres (cm) 
└─┴─┴─┘. └─┘ 
M3 
79 
Weight   
If too large for scale, code 666.6 
 
in Kilograms (kg) 
└─┴─┴─┘.└─┘ 
M4 
80 for women) Are you pregnant? 
Yes 1 
M5 
No 2 
CORE:  Waist 
81 Device IDs for Waist 
 └─┴─┴─┘       M6 
82 
Waist circumference  
 
  in Centimetres (cm) 
└─┴─┴─┘.└─┘ 
M7 
83 Hip Circumference 
  in Centimetres (cm) 
└─┴─┴─┘.└─┘ 
M8 
 
CORE:  Blood Pressure 
84 
Device ID for blood pressure 
 
 
└─┴─┘ 
M10 
85 
Cuff size used 
 
Small 1 
M11 Medium 2 
Large 3 
86 
Reading 1 
 
                   Systolic ( mmHg) └─┴─┴─┘ M12a 
Diastolic (mmHg) └─┴─┴─┘ M12b 
87 
Reading 2 
 
Systolic ( mmHg)  
└─┴─┴─┘  M13a 
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Diastolic (mmHg) └─┴─┴─┘ M13b 
88 
Reading 3 
 
Systolic ( mmHg) 
└─┴─┴─┘ M14a 
Diastolic (mmHg) └─┴─┴─┘ M14b 
89 
During the past two weeks, have you been treated for 
raised blood pressure with drugs (medication) 
prescribed by a doctor or other health worker? 
 
Yes 1 
M15 
No 2 
Heart Rate is (Record if automatic blood pressure device is used) 
90 
Reading 1 
Beat per minute 
└─┴─┴─┘ 
M8a 
Reading 2 
Beat per minute 
└─┴─┴─┘ 
M8b 
Reading 3 
Beat per minute 
└─┴─┴─┘ 
M8c 
 
 
Step 3    Biochemical Measurements 
 
CORE:  Blood Glucose 
Question Response Code 
91 
During the past 12 hours have you had anything to eat 
or drink, other than water? 
Yes 1 
B1 
No 2 
92 Technician ID  
 └─┴─┴─┘ B2 
93 Device ID  
 └─┴─┘ B3 
94 Time of day blood specimen taken (24 hour clock) Hours : minutes 
└─┴─┘: └─┴─┘ 
      hrs            mins 
B4 
95 
Fasting blood glucose 
Choose accordingly: mmol/l or mg/dl 
mmol/l └─┴─┘. └─┴─┘ B5 
mg/dl └─┴─┴─┘.└─┘ 
  Low                       1  
 
 
 
 
  High                       2  └─┘ 
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  Unable to assess   3   
CORE: Blood Lipids 
96 Technician ID  
 └─┴─┴─┘ B6 
97 Device ID  
 
└─┴─┘ 
B7 
98 
Total cholesterol 
Choose accordingly: mmol/l or mg/dl 
mmol/l └─┴─┘. └─┴─┘ 
B8 
mg/dl └─┴─┴─┘.└─┘ 
Low                       1  
High                       2  └─┘ 
Unable to assess   3  
 
EXPANDED:  Triglycerides and HDL Cholesterol 
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Triglycerides 
Choose accordingly: mmol/l or mg/dl 
mmol/l 
└─┴─┘. └─┴─┘ B11 
mg/dl └─┴─┴─┘.└─┘ 
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HDL Cholesterol 
Choose accordingly: mmol/l or mg/dl 
mmol/l └─┘. └─┴─┘ B12 
mg/dl └─┴─┴─┘.└─┘ 
  Low                       1   
  High                       2  └─┘  
  Unable to assess   3   
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Appendix 5 
Declaration of consent 
 
o I have received information about the health survey on burden of risk factors that can 
affect the health 
o I have known the purposes of study and content of the investigation. 
o I agree to I can be contacted and invited to attend a simple physical examination. 
o I agree that my blood sample will be used to medical research. 
o I agree that the result of health check can be used to medical research. 
 
Please cross out any item or items to which you do not give your consent. 
 
 
Place  -------------------------     
Date  ------------------------- 
Signature -------------------------  Signature of Interviewer -----------------------
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Appendix 6 
Participant Feedback Form 
Dear Mr/Ms…………………,     Date ……………………….. 
We thank you very much for participating in the Health survey in ……….., at ….., date……. 
This study was undertaken in order to gather information on the risk factors for chronic diseases 
( e.g cardiovascular diseases, hypertension, diabetes etc) in Yangon region.  
 
We would like to provide you with an overview of your results from the physical 
measurements. 
 
Blood 
pressure 
 
Systolic: ______________________ mmHg  
 
Diastolic: _____________________ mmHg  
 
Blood 
pressure 
classification 
 
 
 
 
 Normal (SBP<140 and DBP<90) 
 Elevated (SBP 140-159 and/or DBP 90-99) 
 Raised (SBP≥160 and/or DBP≥100) 
 Currently on medication 
 
 
Height Height: ______________________ cm 
 
Weight Weight: ______________________ kg 
 
Body Mass 
Index 
BMI: ________________________ kg/m
2 
 
BMI 
classification 
 
 
 
  
 Underweight (BMI<18.5) 
 Normal weight (BMI 18.5-24.9) 
 Overweight (BMI 25-29.9) 
 Obese (BMI≥30) 
 
Waist 
circumference 
Waist: ______________________ cm 
 
Hip 
circumference 
Hip: ________________________ cm 
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 We would like to provide you an overview of your result from biochemical measurements. The 
blood sample was investigated at National Health Laboratory, Yangon. 
 
 
 
Fasting blood 
glucose 
 
 
Fasting blood glucose: ______________________ mmol/l 
Fasting blood 
glucose 
classification 
 
 
 
 Normal (<7.0 mmol/l) 
 Raised (≥7.0 mmol/l) 
 Currently on medication 
 
Total blood 
cholesterol 
Total cholesterol: ______________________ mmol/l 
Total blood 
cholesterol 
classification 
 
 
 
 Normal (<5.0 mmol/l) 
 Elevated (5.0-6.1 mmol/l)  
 High (≥6.2 mmol/l) 
 
HDL 
cholesterol 
 
HDL cholesterol: ______________________ mmol/l 
HDL 
cholesterol 
classification 
 
 Normal (≥1.03 mmol/l for Men, ≥ 1.29 mmol/l for Women) 
 Low (<1.03 mmol/l for Men, <1.29 for Women) 
 
Triglycerides 
 
Triglycerides: ______________________ mmol/l 
Triglycerides 
classification 
 
 Normal (<2.0 mmol/l) 
 Raised (≥2.0 mmol/l)   
 
 
 
Regards, 
 
 
Dr. Aung Soe Htet 
Principal Investigator 
09-31240299 
Email: aungsh@gmail.com 
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Appendix 7     
SHOW CARDS 
Alcohol 
One standard drink = 
                                                                                   
1 Standard measure             1 Single measure of  1 Single measure          
  Of Spirits (30ml)                bottle of beer (285 ml)           glass of wine (120ml)      
 
Note: net alcohol content of a standard drink is approximately 10g of ethanol.  
Therefore, local palm juice is considered as beer.  
 
Fruits and vegetables: One standard serving = 80 grams of fruits and/or vegetables 
Vegetables  
Raw green leafy vegetables     = 1 cup 
Other vegetables, cooked or chopped raw    =  ½ cup 
Vegetable juices                       =  ½ cup     
 
Fruits 
Banana, Apple, Oranges   = 1 piece of medium size fruits 
Chopped, cooked, canned fruit  =  ½ cup 
Fruit juice (not artificial )   =  ½ cup 
 
Example for fruits and vegetables 
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 Example for Vigorous Activity at work 
   
Example for Vigorous Activity at leisure time 
 
   
Example for Moderate Activity at work 
  
Example for Moderate Activity at leisure time 
 
  
102
Physical Activity Table 
Work related Physical Activity Leisure/ Spare time related Physical Activity 
Moderate  
   Intensity Activities 
   Make your breathe much 
harder than normal 
        Vigorous 
       Intensity Activities 
Make your breathe much 
harder than normal 
     Moderate  
         Intensity Activities 
Make your breathe much  
harder than normal 
          Vigorous 
         Intensity Activities 
Make your breathe much harder 
than normal 
Examples: 
• Cleaning (vacuuming, 
mopping, polishing, 
scrubbing, sweeping, 
ironing) 
• Washing (beating and 
brushing carpets, wringing 
clothes (by hand) 
• Gardening 
• Milking cows (by hand) 
• Planting and harvesting crops 
• Digging dry soil (with spade) 
• Weaving 
• Woodwork (chiselling, 
sawing softwood) 
• Mixing cement (with shovel) 
• Labouring (pushing 
loaded wheelbarrow, 
operating jackhammer) 
• Walking with load on head 
• Drawing water 
• Tending animals 
Examples: 
• Forestry (cutting, 
chopping, carrying wood) 
• Sawing hardwood 
• Ploughing 
• Cutting crops (sugar cane) 
• Gardening (digging) 
• Grinding (with pestle) 
• Labouring (shovelling sand) 
• Loading furniture (stoves, 
fridge) 
• Instructing spinning (fitness) 
• Instructing sports aerobics 
• Sorting postal parcels (fast 
pace) 
• Cycle rickshaw driving 
Examples: 
• Cycling 
• Jogging 
• Dancing 
• Horse-riding 
• Tai chi 
• Yoga 
• Pilates 
• Low-impact aerobics 
• Cricket 
Examples 
• Soccer 
• Rugby 
• Tennis 
• High-impact aerobics 
• Aqua aerobics 
• Ballet dancing 
• Fast swimming 
 
103
